Cayman

Showing 21601–21750 of 45550 results

  • Ganglioside GM2 asialo (asialo- GM2; Item No. 24629) is a glycosphingolipid containing three monosaccharide residues and a fatty acid of variable chain length but lacking the sialic acid residue present on ganglioside M2. Asialo-GM2 levels are low-to-undetectable in normal human brain, but it accumulates in the brain of patients with Tay-Sachs and Sandhoff disease, which are neurodegenerative disorders characterized by deficiency of lysosomal β-hexosaminidase A and B, respectively.{40891} It also binds to various bacteria, including Pseudomonas isolates derived from cystic fibrosis patients.{40892} Ganglioside GM2 Asialo Polyclonal Antibody can be used for ELISA and TLC immunoblotting. [Matreya, LLC. Catalog No. 1951]  

     

    Brand:
    Cayman
    SKU:28639 - 50 µl

    Available on backorder

  • Immunogen: Purified ganglioside GM2 Asialo and complete Freund’s adjuvant• Host: Rabbit • Applications: ELISA and TLC immunoblotting  

     

    Brand:
    Cayman
    SKU:28639- 50 µl

    Available on backorder

  • Immunogen: Purified ganglioside GM2 Asialo and complete Freund’s adjuvant• Host: Rabbit • Applications: ELISA and TLC immunoblotting  

     

    Brand:
    Cayman
    SKU:28639- 50 µl
  • Ganglioside GM2 is a glycosphingolipid component of cellular membranes, primarily the plasma membrane.{43702} Gangliosides isolated from apoptogenic glioblastoma multiforme (GBM) cells are enriched in ganglioside GM2 compared with nonapoptogenic GBM cells, and ganglioside GM2 induces activated T cell death when used at a concentration of 150 μg/ml in vitro.{61125} Serum ganglioside GM2 levels are increased in patients with breast cancer or cholangiocarcinoma.{61126,61127} Levels of ganglioside GM2 are elevated in the brain of patients with Sandhoff disease, as well as feline and mouse models of the disease.{40891} Ganglioside GM2 accumulates in the lysosomes of individuals with Tay-Sachs disease and GM2-activator deficiency, as well as in the CNS of patients with and animal models of mucopolysaccharide storage disorders and Niemann-Pick disease types A, C1, and C2.{40891,43703} Ganglioside GM2 mixture contains ganglioside GM2 molecular species isolated from bovine brain with primarily C18:0 fatty acyl chain lengths. [Matreya, LLC. Catalog No. 1542]  

     

    Brand:
    Cayman
    SKU:31710 - 1 mg

    Available on backorder

  • Ganglioside GM2 is a glycosphingolipid component of cellular membranes, primarily the plasma membrane.{43702} Gangliosides isolated from apoptogenic glioblastoma multiforme (GBM) cells are enriched in ganglioside GM2 compared with nonapoptogenic GBM cells, and ganglioside GM2 induces activated T cell death when used at a concentration of 150 μg/ml in vitro.{61125} Serum ganglioside GM2 levels are increased in patients with breast cancer or cholangiocarcinoma.{61126,61127} Levels of ganglioside GM2 are elevated in the brain of patients with Sandhoff disease, as well as feline and mouse models of the disease.{40891} Ganglioside GM2 accumulates in the lysosomes of individuals with Tay-Sachs disease and GM2-activator deficiency, as well as in the CNS of patients with and animal models of mucopolysaccharide storage disorders and Niemann-Pick disease types A, C1, and C2.{40891,43703} Ganglioside GM2 mixture contains ganglioside GM2 molecular species isolated from bovine brain with primarily C18:0 fatty acyl chain lengths. [Matreya, LLC. Catalog No. 1542]  

     

    Brand:
    Cayman
    SKU:31710 - 500 µg

    Available on backorder

  • Ganglioside GM2 is a glycosphingolipid component of cellular membranes, primarily the plasma membrane.{43702} Gangliosides isolated from apoptogenic glioblastoma multiforme (GBM) cells are enriched in ganglioside GM2 compared with nonapoptogenic GBM cells, and ganglioside GM2 induces activated T cell death when used at a concentration of 150 μg/ml in vitro.{61125} Serum ganglioside GM2 levels are increased in patients with breast cancer or cholangiocarcinoma.{61126,61127} Levels of ganglioside GM2 are elevated in the brain of patients with Sandhoff disease, as well as feline and mouse models of the disease.{40891} Ganglioside GM2 accumulates in the lysosomes of individuals with Tay-Sachs disease and GM2-activator deficiency, as well as in the CNS of patients with and animal models of mucopolysaccharide storage disorders and Niemann-Pick disease types A, C1, and C2.{40891,43703} Ganglioside GM2 mixture contains ganglioside GM2 molecular species with C18:1 and C20:1 sphingoid backbones.  

     

    Brand:
    Cayman
    SKU:27192 - 500 µg

    Available on backorder

  • Ganglioside GM3 is a monosialoganglioside that demonstrates antiproliferative and pro-apoptotic effects in tumor cells by modulating cell adhesion, proliferation, and differentiation.{25490,25485} It suppresses angiogenesis and reduces proliferation and migration of human umbilical vein endothelial cells (HUVECs) when used at a concentration of 20 μM via inhibition of VEGFR2 and Akt phosphorylation.{25490,25485} Ganglioside GM3 induces dissociation of the insulin receptor-caveolin-1 complex from lipid microdomains, functioning as an inhibitor of insulin signaling and contributing to insulin resistance in adipocytes.{25481} Ganglioside GM3 mixture contains ganglioside GM3 molecular species with variable fatty acyl chain lengths. [Matreya, LLC. Catalog No. 1503]  

     

    Brand:
    Cayman
    SKU:31711 - 1 mg

    Available on backorder

  • Ganglioside GM3 is a monosialoganglioside that demonstrates antiproliferative and pro-apoptotic effects in tumor cells by modulating cell adhesion, proliferation, and differentiation.{25490,25485} It suppresses angiogenesis and reduces proliferation and migration of human umbilical vein endothelial cells (HUVECs) when used at a concentration of 20 μM via inhibition of VEGFR2 and Akt phosphorylation.{25490,25485} Ganglioside GM3 induces dissociation of the insulin receptor-caveolin-1 complex from lipid microdomains, functioning as an inhibitor of insulin signaling and contributing to insulin resistance in adipocytes.{25481} Ganglioside GM3 mixture contains ganglioside GM3 molecular species with variable fatty acyl chain lengths. [Matreya, LLC. Catalog No. 1503]  

     

    Brand:
    Cayman
    SKU:31711 - 5 mg

    Available on backorder

  • Ganglioside GM3 is a monosialoganglioside that demonstrates antiproliferative and pro-apoptotic effects in tumor cells by modulating cell adhesion, proliferation, and differentiation.{25490,25485} It suppresses angiogenesis and reduces proliferation and migration of human umbilical vein endothelial cells (HUVECs) when used at a concentration of 20 μM via inhibition of VEGFR2 and Akt phosphorylation.{25490,25485} Ganglioside GM3 induces dissociation of the insulin receptor-caveolin-1 complex from lipid microdomains, functioning as an inhibitor of insulin signaling and contributing to insulin resistance in adipocytes.{25481} Ganglioside GM3 mixture contains ganglioside GM3 molecular species with C18:1 and C20:1 sphingoid backbones.  

     

    Brand:
    Cayman
    SKU:-
  • Ganglioside GQ1b is a tetrasialoganglioside that contains two sialic acid residues linked to an inner galactose unit. It stimulates phosphorylation of several ecto-type protein kinase substrates on the surface of GOTO human neuroblastoma cells when used at a concentration of 5 nM.{25486} Ganglioside GQ1b promotes differentiation of murine embryonic stem cells (mESCs) to neuronal precursor and glial cells via activation of the ERK1/2 pathway.{25483} It also induces differentiation of murine keratinocytes through phosphoinositide turnover.{25487} Ganglioside GQ1b mixture contains ganglioside GQ1b molecular species with variable fatty acyl chain lengths. [Matreya, LLC. Catalog No. 1516]  

     

    Brand:
    Cayman
    SKU:31561 - 1 mg

    Available on backorder

  • Ganglioside GQ1b is a tetrasialoganglioside that contains two sialic acid residues linked to an inner galactose unit. It stimulates phosphorylation of several ecto-type protein kinase substrates on the surface of GOTO human neuroblastoma cells when used at a concentration of 5 nM.{25486} Ganglioside GQ1b promotes differentiation of murine embryonic stem cells (mESCs) to neuronal precursor and glial cells via activation of the ERK1/2 pathway.{25483} It also induces differentiation of murine keratinocytes through phosphoinositide turnover.{25487} Ganglioside GQ1b mixture contains ganglioside GQ1b molecular species with variable fatty acyl chain lengths. [Matreya, LLC. Catalog No. 1516]  

     

    Brand:
    Cayman
    SKU:31561 - 100 µg

    Available on backorder

  • Ganglioside GQ1b is a tetrasialoganglioside that contains two sialic acid residues linked to an inner galactose unit. It stimulates phosphorylation of several ecto-type protein kinase substrates on the surface of GOTO human neuroblastoma cells when used at a concentration of 5 nM.{25486} Ganglioside GQ1b promotes differentiation of murine embryonic stem cells (mESCs) to neuronal precursor and glial cells via activation of the ERK1/2 pathway.{25483} It also induces differentiation of murine keratinocytes through phosphoinositide turnover.{25487} Ganglioside GQ1b mixture contains ganglioside GQ1b molecular species isolated from porcine brain with primarily C18:0 fatty acyl chain lengths, as well as a lower amount of C20:0 fatty acyl chain lengths, among various others. [Matreya, LLC. Catalog No. 1549]  

     

    Brand:
    Cayman
    SKU:31562 - 1 mg

    Available on backorder

  • Ganglioside GQ1b is a tetrasialoganglioside that contains two sialic acid residues linked to an inner galactose unit. It stimulates phosphorylation of several ecto-type protein kinase substrates on the surface of GOTO human neuroblastoma cells when used at a concentration of 5 nM.{25486} Ganglioside GQ1b promotes differentiation of murine embryonic stem cells (mESCs) to neuronal precursor and glial cells via activation of the ERK1/2 pathway.{25483} It also induces differentiation of murine keratinocytes through phosphoinositide turnover.{25487} Ganglioside GQ1b mixture contains ganglioside GQ1b molecular species isolated from porcine brain with primarily C18:0 fatty acyl chain lengths, as well as a lower amount of C20:0 fatty acyl chain lengths, among various others. [Matreya, LLC. Catalog No. 1549]  

     

    Brand:
    Cayman
    SKU:31562 - 100 µg

    Available on backorder

  • Ganglioside GQ1b is a tetrasialoganglioside that contains two sialic acid residues linked to an inner galactose unit. It stimulates phosphorylation of several ecto-type protein kinase substrates on the surface of GOTO human neuroblastoma cells when used at a concentration of 5 nM.{25486} Ganglioside GQ1b promotes differentiation of murine embryonic stem cells (mESCs) to neuronal precursor and glial cells via activation of the ERK1/2 pathway.{25483} It also induces differentiation of murine keratinocytes through phosphoinositide turnover.{25487} Ganglioside GQ1b mixture contains ganglioside GQ1b molecular species with C18:1 and C20:1 sphingoid backbones.  

     

    Brand:
    Cayman
    SKU:-
  • Ganglioside GQ1b is a tetrasialoganglioside that contains two sialic acid residues linked to an inner galactose unit. It stimulates phosphorylation of several ecto-type protein kinase substrates on the surface of GOTO human neuroblastoma cells when used at a concentration of 5 nM.{25486} Ganglioside GQ1b promotes differentiation of murine embryonic stem cells (mESCs) to neuronal precursor and glial cells via activation of the ERK1/2 pathway.{25483} It also induces differentiation of murine keratinocytes through phosphoinositide turnover.{25487} Ganglioside GQ1b mixture contains ganglioside GQ1b molecular species with C18:1 and C20:1 sphingoid backbones.  

     

    Brand:
    Cayman
    SKU:-
  • Ganglioside GT1b is a trisialoganglioside that is characterized by having two sialic residues linked to the inner galactose unit. It binds to the neurotoxins botulinum toxin serotype A (BTxA), BTxA heavy chain, and tetanus toxin with IC50 values of 11, 0.74, and 7.2 μM, respectively.{37775} Ganglioside GT1b-containing liposomes bind to the major coat protein VP1 from Merkel cell polyomavirus (MCPyV), which has been identified in Merkel cell carcinomas, identifying ganglioside GT1b as a putative MCPyV receptor.{25480} Ganglioside GT1b decreases spontaneous production of IL-6, IL-10, IgG, IgM, and IgA in human peripheral blood mononuclear cells (PBMCs) by 31.4, 30.5, 60, 59.5, and 58%, respectively, when used at a concentration of 10 μM.{25482} Ganglioside GT1b Mixture contains bovine ganglioside GT1b molecular species with variable fatty acyl chain lengths. [Matreya, LLC. Catalog No. 1063]  

     

    Brand:
    Cayman
    SKU:31712 - 1 mg

    Available on backorder

  • Ganglioside GT1b is a trisialoganglioside that is characterized by having two sialic residues linked to the inner galactose unit. It binds to the neurotoxins botulinum toxin serotype A (BTxA), BTxA heavy chain, and tetanus toxin with IC50 values of 11, 0.74, and 7.2 μM, respectively.{37775} Ganglioside GT1b-containing liposomes bind to the major coat protein VP1 from Merkel cell polyomavirus (MCPyV), which has been identified in Merkel cell carcinomas, identifying ganglioside GT1b as a putative MCPyV receptor.{25480} Ganglioside GT1b decreases spontaneous production of IL-6, IL-10, IgG, IgM, and IgA in human peripheral blood mononuclear cells (PBMCs) by 31.4, 30.5, 60, 59.5, and 58%, respectively, when used at a concentration of 10 μM.{25482} Ganglioside GT1b Mixture contains bovine ganglioside GT1b molecular species with variable fatty acyl chain lengths. [Matreya, LLC. Catalog No. 1063]  

     

    Brand:
    Cayman
    SKU:31712 - 5 mg

    Available on backorder

  • Ganglioside GT1b is a trisialoganglioside that is characterized by having two sialic residues linked to the inner galactose unit. It binds to the neurotoxins botulinum toxin serotype A (BTxA), BTxA heavy chain, and tetanus toxin with IC50 values of 11, 0.74, and 7.2 μM, respectively.{37775} Ganglioside GT1b-containing liposomes bind to the major coat protein VP1 from Merkel cell polyomavirus (MCPyV), which has been identified in Merkel cell carcinomas, identifying ganglioside GT1b as a putative MCPyV receptor.{25480} Ganglioside GT1b decreases spontaneous production of IL-6, IL-10, IgG, IgM, and IgA in human peripheral blood mononuclear cells (PBMCs) by 31.4, 30.5, 60, 59.5, and 58%, respectively, when used at a concentration of 10 μM.{25482} Ganglioside GT1b mixture contains porcine ganglioside GT1b molecular species with primarily C18:0 fatty acyl chain lengths, as well as a lower amount of C20:0 fatty acyl chain lengths, among various others.[Matreya, LLC. Catalog Number. 1548]  

     

    Brand:
    Cayman
    SKU:31592 - 1 mg

    Available on backorder

  • Ganglioside GT1b is a trisialoganglioside that is characterized by having two sialic residues linked to the inner galactose unit. It binds to the neurotoxins botulinum toxin serotype A (BTxA), BTxA heavy chain, and tetanus toxin with IC50 values of 11, 0.74, and 7.2 μM, respectively.{37775} Ganglioside GT1b-containing liposomes bind to the major coat protein VP1 from Merkel cell polyomavirus (MCPyV), which has been identified in Merkel cell carcinomas, identifying ganglioside GT1b as a putative MCPyV receptor.{25480} Ganglioside GT1b decreases spontaneous production of IL-6, IL-10, IgG, IgM, and IgA in human peripheral blood mononuclear cells (PBMCs) by 31.4, 30.5, 60, 59.5, and 58%, respectively, when used at a concentration of 10 μM.{25482} Ganglioside GT1b mixture contains porcine ganglioside GT1b molecular species with primarily C18:0 fatty acyl chain lengths, as well as a lower amount of C20:0 fatty acyl chain lengths, among various others.[Matreya, LLC. Catalog Number. 1548]  

     

    Brand:
    Cayman
    SKU:31592 - 5 mg

    Available on backorder

  • Ganirelix is a gonadotropin-releasing hormone receptor (GNRHR) antagonist (IC50 = 3.6 nM; pA2 = 9.3).{39553} It induces a concentration-dependent increase in histamine release from rat peritoneal mast cells in vitro (EC50 = 11 μg/ml).{40810} In vivo, ganirelix (2 mg/kg, s.c.) decreases plasma testosterone in intact male rats for the first 7 days post-administration. Ganirelix (125 μg per day for 30 days) decreases the surface area of endometriotic lesions and serum progesterone levels in female baboons.{40811} Formulations containing ganirelix have been used to prevent premature ovulation in women undergoing in vitro fertilization.  

     

    Brand:
    Cayman
    SKU:24098 - 1 mg

    Available on backorder

  • Ganirelix is a gonadotropin-releasing hormone receptor (GNRHR) antagonist (IC50 = 3.6 nM; pA2 = 9.3).{39553} It induces a concentration-dependent increase in histamine release from rat peritoneal mast cells in vitro (EC50 = 11 μg/ml).{40810} In vivo, ganirelix (2 mg/kg, s.c.) decreases plasma testosterone in intact male rats for the first 7 days post-administration. Ganirelix (125 μg per day for 30 days) decreases the surface area of endometriotic lesions and serum progesterone levels in female baboons.{40811} Formulations containing ganirelix have been used to prevent premature ovulation in women undergoing in vitro fertilization.  

     

    Brand:
    Cayman
    SKU:24098 - 10 mg

    Available on backorder

  • Ganirelix is a gonadotropin-releasing hormone receptor (GNRHR) antagonist (IC50 = 3.6 nM; pA2 = 9.3).{39553} It induces a concentration-dependent increase in histamine release from rat peritoneal mast cells in vitro (EC50 = 11 μg/ml).{40810} In vivo, ganirelix (2 mg/kg, s.c.) decreases plasma testosterone in intact male rats for the first 7 days post-administration. Ganirelix (125 μg per day for 30 days) decreases the surface area of endometriotic lesions and serum progesterone levels in female baboons.{40811} Formulations containing ganirelix have been used to prevent premature ovulation in women undergoing in vitro fertilization.  

     

    Brand:
    Cayman
    SKU:24098 - 5 mg

    Available on backorder

  • Ganirelix is a gonadotropin-releasing hormone receptor (GNRHR) antagonist (IC50 = 3.6 nM; pA2 = 9.3).{39553} It induces a concentration-dependent increase in histamine release from rat peritoneal mast cells in vitro (EC50 = 11 μg/ml).{40810} In vivo, ganirelix (2 mg/kg, s.c.) decreases plasma testosterone in intact male rats for the first 7 days post-administration. Ganirelix (125 μg per day for 30 days) decreases the surface area of endometriotic lesions and serum progesterone levels in female baboons.{40811} Formulations containing ganirelix have been used to prevent premature ovulation in women undergoing in vitro fertilization.  

     

    Brand:
    Cayman
    SKU:24098 - 500 µg

    Available on backorder

  • Ganoderenic acid A is a triterpenoid originally isolated from G. lucidum that has enzyme inhibitory activities.{48894,48895,48896} It is an inhibitor of β-glucuronidase (IC50 = 0.12 mg/ml in rat liver microsomes).{48895} Ganoderenic acid A (100 mg/kg) reduces increases in serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH) in a rat model of liver injury induced by carbon tetrachloride (CCl4). It also inhibits aldose reductase by 54.2% when used at a concentration of 100 µg/ml.{48896}  

     

    Brand:
    Cayman
    SKU:27685 - 1 mg

    Available on backorder

  • Ganoderenic acid A is a triterpenoid originally isolated from G. lucidum that has enzyme inhibitory activities.{48894,48895,48896} It is an inhibitor of β-glucuronidase (IC50 = 0.12 mg/ml in rat liver microsomes).{48895} Ganoderenic acid A (100 mg/kg) reduces increases in serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH) in a rat model of liver injury induced by carbon tetrachloride (CCl4). It also inhibits aldose reductase by 54.2% when used at a concentration of 100 µg/ml.{48896}  

     

    Brand:
    Cayman
    SKU:27685 - 10 mg

    Available on backorder

  • Ganoderenic acid A is a triterpenoid originally isolated from G. lucidum that has enzyme inhibitory activities.{48894,48895,48896} It is an inhibitor of β-glucuronidase (IC50 = 0.12 mg/ml in rat liver microsomes).{48895} Ganoderenic acid A (100 mg/kg) reduces increases in serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH) in a rat model of liver injury induced by carbon tetrachloride (CCl4). It also inhibits aldose reductase by 54.2% when used at a concentration of 100 µg/ml.{48896}  

     

    Brand:
    Cayman
    SKU:27685 - 5 mg

    Available on backorder

  • Ganoderenic acid C is a triterpene that has been found in G. lucidum.{48894} It is cytotoxic to H460 cancer cells (IC50 = 93 µM).  

     

    Brand:
    Cayman
    SKU:30366 - 1 mg

    Available on backorder

  • Ganoderenic acid C is a triterpene that has been found in G. lucidum.{48894} It is cytotoxic to H460 cancer cells (IC50 = 93 µM).  

     

    Brand:
    Cayman
    SKU:30366 - 10 mg

    Available on backorder

  • Ganoderenic acid C is a triterpene that has been found in G. lucidum.{48894} It is cytotoxic to H460 cancer cells (IC50 = 93 µM).  

     

    Brand:
    Cayman
    SKU:30366 - 5 mg

    Available on backorder

  • Ganoderic acid A is a triterpene that has been found in Ganoderma and has diverse biological activities.{47541,47542,47543,47544,47545} It reduces cell viability, expression of superoxide dismutase 1 (SOD1), SOD2, and SOD3, and production of reactive oxygen species (ROS) in PC3 prostate cancer cells.{47541} Ganoderic acid A (2-100 μg/ml) reduces hypoxia-induced apoptosis in H9c2 cardiomyocytes.{47542} It inhibits LPS-induced activation of NF-κB, release of TNF-α, IL-1β, and IL-6, and mitochondrial activity in primary mouse cortical microglia.{47543} Ganoderic acid A (20 and 40 mg/kg) reduces lung myeloperoxidase (MPO) activity, neutrophil infiltration, and NF-κB signaling, as well as bronchoalveolar lavage fluid (BALF) levels of TNF-α, IL-1β, and IL-6 in a mouse model of LPS-induced lung injury.{47544} It also reduces weight gain and hepatic lipid accumulation and improves insulin sensitivity in a mouse model of high-fat diet-induced obesity.{47545}  

     

    Brand:
    Cayman
    SKU:26674 - 10 mg

    Available on backorder

  • Ganoderic acid A is a triterpene that has been found in Ganoderma and has diverse biological activities.{47541,47542,47543,47544,47545} It reduces cell viability, expression of superoxide dismutase 1 (SOD1), SOD2, and SOD3, and production of reactive oxygen species (ROS) in PC3 prostate cancer cells.{47541} Ganoderic acid A (2-100 μg/ml) reduces hypoxia-induced apoptosis in H9c2 cardiomyocytes.{47542} It inhibits LPS-induced activation of NF-κB, release of TNF-α, IL-1β, and IL-6, and mitochondrial activity in primary mouse cortical microglia.{47543} Ganoderic acid A (20 and 40 mg/kg) reduces lung myeloperoxidase (MPO) activity, neutrophil infiltration, and NF-κB signaling, as well as bronchoalveolar lavage fluid (BALF) levels of TNF-α, IL-1β, and IL-6 in a mouse model of LPS-induced lung injury.{47544} It also reduces weight gain and hepatic lipid accumulation and improves insulin sensitivity in a mouse model of high-fat diet-induced obesity.{47545}  

     

    Brand:
    Cayman
    SKU:26674 - 25 mg

    Available on backorder

  • Ganoderic acid A is a triterpene that has been found in Ganoderma and has diverse biological activities.{47541,47542,47543,47544,47545} It reduces cell viability, expression of superoxide dismutase 1 (SOD1), SOD2, and SOD3, and production of reactive oxygen species (ROS) in PC3 prostate cancer cells.{47541} Ganoderic acid A (2-100 μg/ml) reduces hypoxia-induced apoptosis in H9c2 cardiomyocytes.{47542} It inhibits LPS-induced activation of NF-κB, release of TNF-α, IL-1β, and IL-6, and mitochondrial activity in primary mouse cortical microglia.{47543} Ganoderic acid A (20 and 40 mg/kg) reduces lung myeloperoxidase (MPO) activity, neutrophil infiltration, and NF-κB signaling, as well as bronchoalveolar lavage fluid (BALF) levels of TNF-α, IL-1β, and IL-6 in a mouse model of LPS-induced lung injury.{47544} It also reduces weight gain and hepatic lipid accumulation and improves insulin sensitivity in a mouse model of high-fat diet-induced obesity.{47545}  

     

    Brand:
    Cayman
    SKU:26674 - 5 mg

    Available on backorder

  • Ganoderic acid A is a triterpene that has been found in Ganoderma and has diverse biological activities.{47541,47542,47543,47544,47545} It reduces cell viability, expression of superoxide dismutase 1 (SOD1), SOD2, and SOD3, and production of reactive oxygen species (ROS) in PC3 prostate cancer cells.{47541} Ganoderic acid A (2-100 μg/ml) reduces hypoxia-induced apoptosis in H9c2 cardiomyocytes.{47542} It inhibits LPS-induced activation of NF-κB, release of TNF-α, IL-1β, and IL-6, and mitochondrial activity in primary mouse cortical microglia.{47543} Ganoderic acid A (20 and 40 mg/kg) reduces lung myeloperoxidase (MPO) activity, neutrophil infiltration, and NF-κB signaling, as well as bronchoalveolar lavage fluid (BALF) levels of TNF-α, IL-1β, and IL-6 in a mouse model of LPS-induced lung injury.{47544} It also reduces weight gain and hepatic lipid accumulation and improves insulin sensitivity in a mouse model of high-fat diet-induced obesity.{47545}  

     

    Brand:
    Cayman
    SKU:26674 - 50 mg

    Available on backorder

  • Ganoderic acid B is a triterpenoid that has been found in G. lucidum and has diverse biological activities.{48842,46302,48844} It inhibits HIV-1 protease with an IC50 value of 0.17 mM.{48842} Ganoderic acid B is cytotoxic to HepG2 and Caco-2 cells (IC50s = 0.65 and 0.36 mg/ml, respectively).{46302} It inhibits acetic acid-induced writhing in mice by 48.3% when administered at a dose of 5 mg/kg.{48844}  

     

    Brand:
    Cayman
    SKU:30112 - 1 mg

    Available on backorder

  • Ganoderic acid B is a triterpenoid that has been found in G. lucidum and has diverse biological activities.{48842,46302,48844} It inhibits HIV-1 protease with an IC50 value of 0.17 mM.{48842} Ganoderic acid B is cytotoxic to HepG2 and Caco-2 cells (IC50s = 0.65 and 0.36 mg/ml, respectively).{46302} It inhibits acetic acid-induced writhing in mice by 48.3% when administered at a dose of 5 mg/kg.{48844}  

     

    Brand:
    Cayman
    SKU:30112 - 10 mg

    Available on backorder

  • Ganoderic acid B is a triterpenoid that has been found in G. lucidum and has diverse biological activities.{48842,46302,48844} It inhibits HIV-1 protease with an IC50 value of 0.17 mM.{48842} Ganoderic acid B is cytotoxic to HepG2 and Caco-2 cells (IC50s = 0.65 and 0.36 mg/ml, respectively).{46302} It inhibits acetic acid-induced writhing in mice by 48.3% when administered at a dose of 5 mg/kg.{48844}  

     

    Brand:
    Cayman
    SKU:30112 - 5 mg

    Available on backorder

  • Ganoderic acid B is a triterpenoid that has been found in G. lucidum and has diverse biological activities.{48842,46302,48844} It inhibits HIV-1 protease with an IC50 value of 0.17 mM.{48842} Ganoderic acid B is cytotoxic to HepG2 and Caco-2 cells (IC50s = 0.65 and 0.36 mg/ml, respectively).{46302} It inhibits acetic acid-induced writhing in mice by 48.3% when administered at a dose of 5 mg/kg.{48844}  

     

    Brand:
    Cayman
    SKU:30112 - 500 µg

    Available on backorder

  • Ganoderic acid C2 is a triterpene that has been found in G. lucidum.{55060} It inhibits histamine release from isolated rat mast cells induced by concanavalin A (Item No. 14951) or compound 48/80 (Item No. 22173) when used at a concentration of 2 mg/ml.  

     

    Brand:
    Cayman
    SKU:30371 - 1 mg

    Available on backorder

  • Ganoderic acid C2 is a triterpene that has been found in G. lucidum.{55060} It inhibits histamine release from isolated rat mast cells induced by concanavalin A (Item No. 14951) or compound 48/80 (Item No. 22173) when used at a concentration of 2 mg/ml.  

     

    Brand:
    Cayman
    SKU:30371 - 10 mg

    Available on backorder

  • Ganoderic acid C2 is a triterpene that has been found in G. lucidum.{55060} It inhibits histamine release from isolated rat mast cells induced by concanavalin A (Item No. 14951) or compound 48/80 (Item No. 22173) when used at a concentration of 2 mg/ml.  

     

    Brand:
    Cayman
    SKU:30371 - 5 mg

    Available on backorder

  • Ganoderic acid D is an oxygenated triterpenoid that has been found in G. lucidum.{46301} It inhibits glucose uptake and lactate production when used at concentrations ranging from 50 to 200 µM and decreases pyruvate and acetyl-coenzyme A production at concentrations of 100 and 200 µM in HT-29 and SW620 colon cancer cells. Ganoderic acid D increases protein levels of sirtuin 3 (SIRT3) in HT-29 and SW620 cells. It is cytotoxic to HepG2, HeLa, and Caco-2 cells with IC50 values of 0.14, 0.18, and 0.02 µg/ml, respectively.{46302}  

     

    Brand:
    Cayman
    SKU:26765 - 1 mg

    Available on backorder

  • Ganoderic acid D is an oxygenated triterpenoid that has been found in G. lucidum.{46301} It inhibits glucose uptake and lactate production when used at concentrations ranging from 50 to 200 µM and decreases pyruvate and acetyl-coenzyme A production at concentrations of 100 and 200 µM in HT-29 and SW620 colon cancer cells. Ganoderic acid D increases protein levels of sirtuin 3 (SIRT3) in HT-29 and SW620 cells. It is cytotoxic to HepG2, HeLa, and Caco-2 cells with IC50 values of 0.14, 0.18, and 0.02 µg/ml, respectively.{46302}  

     

    Brand:
    Cayman
    SKU:26765 - 10 mg

    Available on backorder

  • Ganoderic acid D is an oxygenated triterpenoid that has been found in G. lucidum.{46301} It inhibits glucose uptake and lactate production when used at concentrations ranging from 50 to 200 µM and decreases pyruvate and acetyl-coenzyme A production at concentrations of 100 and 200 µM in HT-29 and SW620 colon cancer cells. Ganoderic acid D increases protein levels of sirtuin 3 (SIRT3) in HT-29 and SW620 cells. It is cytotoxic to HepG2, HeLa, and Caco-2 cells with IC50 values of 0.14, 0.18, and 0.02 µg/ml, respectively.{46302}  

     

    Brand:
    Cayman
    SKU:26765 - 25 mg

    Available on backorder

  • Ganoderic acid D is an oxygenated triterpenoid that has been found in G. lucidum.{46301} It inhibits glucose uptake and lactate production when used at concentrations ranging from 50 to 200 µM and decreases pyruvate and acetyl-coenzyme A production at concentrations of 100 and 200 µM in HT-29 and SW620 colon cancer cells. Ganoderic acid D increases protein levels of sirtuin 3 (SIRT3) in HT-29 and SW620 cells. It is cytotoxic to HepG2, HeLa, and Caco-2 cells with IC50 values of 0.14, 0.18, and 0.02 µg/ml, respectively.{46302}  

     

    Brand:
    Cayman
    SKU:26765 - 5 mg

    Available on backorder

  • Ganoderic acid H is a triterpene that has been found in G. lucidum and has diverse biological activities.{48841,48842,48843,48844} It inhibits angiotensin-converting enzyme (ACE; IC50 = 26 µM).{48841} Ganoderic acid H also inhibits HIV-1 protease with an IC50 value of 200 µM.{48842} It reduces colony formation and migration of MDA-MB-231 breast cancer cells in a concentration-dependent manner.{48843} In vivo, ganoderic acid H (1, 3, and 5 mg/kg) inhibits acetic acid-induced writhing in mice.{48844}  

     

    Brand:
    Cayman
    SKU:29703 - 1 mg

    Available on backorder

  • Ganoderic acid H is a triterpene that has been found in G. lucidum and has diverse biological activities.{48841,48842,48843,48844} It inhibits angiotensin-converting enzyme (ACE; IC50 = 26 µM).{48841} Ganoderic acid H also inhibits HIV-1 protease with an IC50 value of 200 µM.{48842} It reduces colony formation and migration of MDA-MB-231 breast cancer cells in a concentration-dependent manner.{48843} In vivo, ganoderic acid H (1, 3, and 5 mg/kg) inhibits acetic acid-induced writhing in mice.{48844}  

     

    Brand:
    Cayman
    SKU:29703 - 5 mg

    Available on backorder

  • Ganoderic acid H is a triterpene that has been found in G. lucidum and has diverse biological activities.{48841,48842,48843,48844} It inhibits angiotensin-converting enzyme (ACE; IC50 = 26 µM).{48841} Ganoderic acid H also inhibits HIV-1 protease with an IC50 value of 200 µM.{48842} It reduces colony formation and migration of MDA-MB-231 breast cancer cells in a concentration-dependent manner.{48843} In vivo, ganoderic acid H (1, 3, and 5 mg/kg) inhibits acetic acid-induced writhing in mice.{48844}  

     

    Brand:
    Cayman
    SKU:29703 - 500 µg

    Available on backorder

  • Hedgehog (hh) proteins, important regulators of development, bind the cell-surface protein Patched, allowing activation of Smoothened (Smo). In vertebrates, this ultimately leads to the activation of the zinc-finger transcription factors of the GLI family. Overactivation of this pathway contributes to certain cancers, including glioblastoma, for which the GLI proteins are named. GANT 58 is a GLI antagonist that inhibits GLI1-mediated transcription (EC50 = 5 μM) in a variety of cell types.{22122,22692,22693} It inhibits the hh signaling pathway downstream of Smo and the endogenous downstream inhibitor Sufu thereby affecting GLI1 nuclear accumulation.{22122} GANT 58 displays antiproliferative and antitumor activity against Ewing sarcoma family of tumor cells.{22692,22693}  

     

    Brand:
    Cayman
    SKU:-
  • Hedgehog (hh) proteins, important regulators of development, bind the cell-surface protein Patched, allowing activation of Smoothened (Smo). In vertebrates, this ultimately leads to the activation of the zinc-finger transcription factors of the GLI family. Overactivation of this pathway contributes to certain cancers, including glioblastoma, for which the GLI proteins are named. GANT 58 is a GLI antagonist that inhibits GLI1-mediated transcription (EC50 = 5 μM) in a variety of cell types.{22122,22692,22693} It inhibits the hh signaling pathway downstream of Smo and the endogenous downstream inhibitor Sufu thereby affecting GLI1 nuclear accumulation.{22122} GANT 58 displays antiproliferative and antitumor activity against Ewing sarcoma family of tumor cells.{22692,22693}  

     

    Brand:
    Cayman
    SKU:-
  • Hedgehog (hh) proteins, important regulators of development, bind the cell-surface protein Patched, allowing activation of Smoothened (Smo). In vertebrates, this ultimately leads to the activation of the zinc-finger transcription factors of the GLI family. Overactivation of this pathway contributes to certain cancers, including glioblastoma, for which the GLI proteins are named. GANT 58 is a GLI antagonist that inhibits GLI1-mediated transcription (EC50 = 5 μM) in a variety of cell types.{22122,22692,22693} It inhibits the hh signaling pathway downstream of Smo and the endogenous downstream inhibitor Sufu thereby affecting GLI1 nuclear accumulation.{22122} GANT 58 displays antiproliferative and antitumor activity against Ewing sarcoma family of tumor cells.{22692,22693}  

     

    Brand:
    Cayman
    SKU:-
  • Hedgehog (hh) proteins, important regulators of development, bind the cell-surface protein Patched, allowing activation of Smoothened (Smo). In vertebrates, this ultimately leads to the activation of the zinc-finger transcription factors of the GLI family. Overactivation of this pathway contributes to certain cancers, including glioblastoma, for which the GLI proteins are named. GANT 58 is a GLI antagonist that inhibits GLI1-mediated transcription (EC50 = 5 μM) in a variety of cell types.{22122,22692,22693} It inhibits the hh signaling pathway downstream of Smo and the endogenous downstream inhibitor Sufu thereby affecting GLI1 nuclear accumulation.{22122} GANT 58 displays antiproliferative and antitumor activity against Ewing sarcoma family of tumor cells.{22692,22693}  

     

    Brand:
    Cayman
    SKU:-
  • Hedgehog proteins, important regulators of development, bind the cell-surface protein Patched, allowing activation of Smoothened. In vertebrates, this ultimately leads to the activation of the zinc-finger transcription factors of the GLI family. Overactivation of this pathway contributes to certain cancers, including glioblastoma, for which the GLI proteins are named. GANT 61 is a GLI antagonist, inhibiting GLI1 activation of gene expression with an IC50 value of 5 μM.{18037} It does not affect signaling through NF-κB, glucocorticoid receptor, MAPK, HGF, C/EBPα, or HIF-1, supporting specificity for the Hedgehog pathway.{18037} GANT 61 has been shown to inhibit the in vitro proliferation of PANC-1 and 22Rv1 cancer cells, which have elevated GLI1 levels, and prevent the development of 22Rv1 tumors in mice.{18037}  

     

    Brand:
    Cayman
    SKU:-
  • Hedgehog proteins, important regulators of development, bind the cell-surface protein Patched, allowing activation of Smoothened. In vertebrates, this ultimately leads to the activation of the zinc-finger transcription factors of the GLI family. Overactivation of this pathway contributes to certain cancers, including glioblastoma, for which the GLI proteins are named. GANT 61 is a GLI antagonist, inhibiting GLI1 activation of gene expression with an IC50 value of 5 μM.{18037} It does not affect signaling through NF-κB, glucocorticoid receptor, MAPK, HGF, C/EBPα, or HIF-1, supporting specificity for the Hedgehog pathway.{18037} GANT 61 has been shown to inhibit the in vitro proliferation of PANC-1 and 22Rv1 cancer cells, which have elevated GLI1 levels, and prevent the development of 22Rv1 tumors in mice.{18037}  

     

    Brand:
    Cayman
    SKU:-
  • Hedgehog proteins, important regulators of development, bind the cell-surface protein Patched, allowing activation of Smoothened. In vertebrates, this ultimately leads to the activation of the zinc-finger transcription factors of the GLI family. Overactivation of this pathway contributes to certain cancers, including glioblastoma, for which the GLI proteins are named. GANT 61 is a GLI antagonist, inhibiting GLI1 activation of gene expression with an IC50 value of 5 μM.{18037} It does not affect signaling through NF-κB, glucocorticoid receptor, MAPK, HGF, C/EBPα, or HIF-1, supporting specificity for the Hedgehog pathway.{18037} GANT 61 has been shown to inhibit the in vitro proliferation of PANC-1 and 22Rv1 cancer cells, which have elevated GLI1 levels, and prevent the development of 22Rv1 tumors in mice.{18037}  

     

    Brand:
    Cayman
    SKU:-
  • Hedgehog proteins, important regulators of development, bind the cell-surface protein Patched, allowing activation of Smoothened. In vertebrates, this ultimately leads to the activation of the zinc-finger transcription factors of the GLI family. Overactivation of this pathway contributes to certain cancers, including glioblastoma, for which the GLI proteins are named. GANT 61 is a GLI antagonist, inhibiting GLI1 activation of gene expression with an IC50 value of 5 μM.{18037} It does not affect signaling through NF-κB, glucocorticoid receptor, MAPK, HGF, C/EBPα, or HIF-1, supporting specificity for the Hedgehog pathway.{18037} GANT 61 has been shown to inhibit the in vitro proliferation of PANC-1 and 22Rv1 cancer cells, which have elevated GLI1 levels, and prevent the development of 22Rv1 tumors in mice.{18037}  

     

    Brand:
    Cayman
    SKU:-
  • Gap-43 is thought to have an important role in development and plasticity because it is expressed at high levels in neuronal growth cones during development and during axonal regeneration.{14428} There is also evidence from knockout animals that Gap-43 serves to amplify path finding signals from the growth cone.{14431} Gap-43 is thought to mediate at least some of these effects via interaction with actin. Importantly, phosphorylation at Ser41 by protein kinase C (Catalog No. 1609-PKC) modulates the interaction of Gap-43 with actin and may also affect neurotransmitter release during forms of plasticity like LTP.{14429,14430}  

     

    Brand:
    Cayman
    SKU:10009400 - 1 ea

    Available on backorder

  • Antigen: phosphopeptide corresponding to amino acid residues surrounding phospho-Ser41 of Gap-43 · Host: rabbit · Cross Reactivity: (+) rat Gap-43; expected to react with bovine, canine, chicken, finch, human, mouse, non-human primates, Xenopus, and zebrafish Gap-43 · Application: WB  

     

    Brand:
    Cayman
    SKU:10009400- 1 ea

    Available on backorder

  • Antigen: phosphopeptide corresponding to amino acid residues surrounding phospho-Ser41 of Gap-43 · Host: rabbit · Cross Reactivity: (+) rat Gap-43; expected to react with bovine, canine, chicken, finch, human, mouse, non-human primates, Xenopus, and zebrafish Gap-43 · Application: WB  

     

    Brand:
    Cayman
    SKU:10009400- 1 ea
  • Immunogen: Peptide from the C-terminal region of GAPDH • Host: Rabbit • Species Reactivity: (+) Species independent • Cross Reactivity: (+) GAPDH • Applications: ICC, IP, ChIP, WB • MW = ~36 kDa  

     

    Brand:
    Cayman
    SKU:32128- 100 µl
  • Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is an enzyme that catalyzes the conversion of glyceraldehyde-3-phosphate (Item No. 17865) to 1,3-bisphosphoglycerate during glycolysis and is involved in numerous additional cellular processes, including intracellular trafficking, receptor-mediated signaling, apoptosis, DNA repair, and the oxidative stress response.{54459,54460} It exists as a tetramer and is composed of an N-terminal domain, which contains binding sites for NAD+, phosphatidylserine, RNA, and glutathione, and a C-terminal catalytic domain.{54461} GAPDH is widely expressed and primarily localizes to the cytosol, where it has roles in glycolysis and intracellular trafficking.{54459,60077} It also localizes to the nucleus, mediating DNA integrity, gene transcription, and apoptosis, as well as to cellular membranes, where it has roles in membrane fusion and iron transport.{60077} GAPDH expression is increased by insulin, hypoxia-inducible factor-1 (HIF-1), p53, and nitric oxide (NO) and decreased by acetylated histones.{54459,54462} Aberrant mRNA and protein levels of GAPDH have been found in tumor biopsies from patients with a variety of cancers, including lung, renal cell, colorectal, or breast cancer.{60078} Cayman’s GAPDH (C-Term) Rabbit Monoclonal Antibody can be used for immunocytochemistry (ICC), immunoprecipitation (IP), chromatin immunoprecipitation (ChIP), and Western blot (WB) applications. The antibody recognizes the C-terminal region of GAPDH at approximately 36 kDa.  

     

    Brand:
    Cayman
    SKU:32128 - 100 µl

    Available on backorder

  • Immunogen: Peptide from the C-terminal region of GAPDH • Host: Rabbit • Species Reactivity: (+) Species independent • Cross Reactivity: (+) GAPDH • Applications: ICC, IP, ChIP, WB • MW = ~36 kDa  

     

    Brand:
    Cayman
    SKU:32128- 100 µl

    Available on backorder

  • Garcinoic acid is a derivative of vitamin E originally isolated from C. grandiflora.{53297} It inhibits IL-1β-induced microsomal prostaglandin E2 synthase-1 (mPGES-1) activity in A549 cells when used at concentrations of 1 and 10 µM.{53298} It has higher antioxidant activity relative to (±)-α-tocopherol (Item No. 25985) in a cell-free assay when used at a concentration of 0.15 mM.{53299}  

     

    Brand:
    Cayman
    SKU:28122 - 1 mg

    Available on backorder

  • Garcinoic acid is a derivative of vitamin E originally isolated from C. grandiflora.{53297} It inhibits IL-1β-induced microsomal prostaglandin E2 synthase-1 (mPGES-1) activity in A549 cells when used at concentrations of 1 and 10 µM.{53298} It has higher antioxidant activity relative to (±)-α-tocopherol (Item No. 25985) in a cell-free assay when used at a concentration of 0.15 mM.{53299}  

     

    Brand:
    Cayman
    SKU:28122 - 250 µg

    Available on backorder

  • Garcinoic acid is a derivative of vitamin E originally isolated from C. grandiflora.{53297} It inhibits IL-1β-induced microsomal prostaglandin E2 synthase-1 (mPGES-1) activity in A549 cells when used at concentrations of 1 and 10 µM.{53298} It has higher antioxidant activity relative to (±)-α-tocopherol (Item No. 25985) in a cell-free assay when used at a concentration of 0.15 mM.{53299}  

     

    Brand:
    Cayman
    SKU:28122 - 500 µg

    Available on backorder

  • Garcinol is an inhibitor of the histone acetyltransferases (HATs) p300 and PCAF (IC50 = 7 and 5 μM, respectively).{14406} It also inhibits the HAT GCN5 in Cryptococcus neoformans, inducing temperature sensitivity and impairing growth.{20146} A polyisoprenylated benzophenone isolated from Garcinia indica, garcinol promotes neurogenesis and ex vivo expansion of human hematopoietic stem cells.{20148,20145} Moreover, it induces apoptosis in several types of cancer cells and has anti-inflammatory actions.{20147,20144}  

     

    Brand:
    Cayman
    SKU:10566 - 10 mg

    Available on backorder

  • Garcinol is an inhibitor of the histone acetyltransferases (HATs) p300 and PCAF (IC50 = 7 and 5 μM, respectively).{14406} It also inhibits the HAT GCN5 in Cryptococcus neoformans, inducing temperature sensitivity and impairing growth.{20146} A polyisoprenylated benzophenone isolated from Garcinia indica, garcinol promotes neurogenesis and ex vivo expansion of human hematopoietic stem cells.{20148,20145} Moreover, it induces apoptosis in several types of cancer cells and has anti-inflammatory actions.{20147,20144}  

     

    Brand:
    Cayman
    SKU:10566 - 25 mg

    Available on backorder

  • Garcinol is an inhibitor of the histone acetyltransferases (HATs) p300 and PCAF (IC50 = 7 and 5 μM, respectively).{14406} It also inhibits the HAT GCN5 in Cryptococcus neoformans, inducing temperature sensitivity and impairing growth.{20146} A polyisoprenylated benzophenone isolated from Garcinia indica, garcinol promotes neurogenesis and ex vivo expansion of human hematopoietic stem cells.{20148,20145} Moreover, it induces apoptosis in several types of cancer cells and has anti-inflammatory actions.{20147,20144}  

     

    Brand:
    Cayman
    SKU:10566 - 5 mg

    Available on backorder

  • Garcinol is an inhibitor of the histone acetyltransferases (HATs) p300 and PCAF (IC50 = 7 and 5 μM, respectively).{14406} It also inhibits the HAT GCN5 in Cryptococcus neoformans, inducing temperature sensitivity and impairing growth.{20146} A polyisoprenylated benzophenone isolated from Garcinia indica, garcinol promotes neurogenesis and ex vivo expansion of human hematopoietic stem cells.{20148,20145} Moreover, it induces apoptosis in several types of cancer cells and has anti-inflammatory actions.{20147,20144}  

     

    Brand:
    Cayman
    SKU:10566 - 50 mg

    Available on backorder

  • Garcinone D is a xanthone that has been found in G. mangostana and has diverse biological activities.{54166} It increases proliferation of C17.2 neural progenitor cells (NPCs) when used at a concentration of 5 µM, an effect that can be reduced by inhibition of the antioxidative transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2). It increases phosphorylation of STAT3 and cyclin D1 and the protein levels of Nrf2 and heme oxygenase-1 (HO-1) in a concentration-dependent manner. Garcinone D (3 µM) inhibits aggregation of amyloid-β (1-42) (Aβ42; Item No. 20574) in vitro and inhibits beta-secretase 1 (BACE1) by 62.7% when used at a concentration of 100 µM.{54167} It scavenges peroxynitrite radicals with an IC50 value of 26.4 µM.{54168}  

     

    Brand:
    Cayman
    SKU:30906 - 1 mg

    Available on backorder

  • Garcinone D is a xanthone that has been found in G. mangostana and has diverse biological activities.{54166} It increases proliferation of C17.2 neural progenitor cells (NPCs) when used at a concentration of 5 µM, an effect that can be reduced by inhibition of the antioxidative transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2). It increases phosphorylation of STAT3 and cyclin D1 and the protein levels of Nrf2 and heme oxygenase-1 (HO-1) in a concentration-dependent manner. Garcinone D (3 µM) inhibits aggregation of amyloid-β (1-42) (Aβ42; Item No. 20574) in vitro and inhibits beta-secretase 1 (BACE1) by 62.7% when used at a concentration of 100 µM.{54167} It scavenges peroxynitrite radicals with an IC50 value of 26.4 µM.{54168}  

     

    Brand:
    Cayman
    SKU:30906 - 10 mg

    Available on backorder

  • Garcinone D is a xanthone that has been found in G. mangostana and has diverse biological activities.{54166} It increases proliferation of C17.2 neural progenitor cells (NPCs) when used at a concentration of 5 µM, an effect that can be reduced by inhibition of the antioxidative transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2). It increases phosphorylation of STAT3 and cyclin D1 and the protein levels of Nrf2 and heme oxygenase-1 (HO-1) in a concentration-dependent manner. Garcinone D (3 µM) inhibits aggregation of amyloid-β (1-42) (Aβ42; Item No. 20574) in vitro and inhibits beta-secretase 1 (BACE1) by 62.7% when used at a concentration of 100 µM.{54167} It scavenges peroxynitrite radicals with an IC50 value of 26.4 µM.{54168}  

     

    Brand:
    Cayman
    SKU:30906 - 25 mg

    Available on backorder

  • Garcinone D is a xanthone that has been found in G. mangostana and has diverse biological activities.{54166} It increases proliferation of C17.2 neural progenitor cells (NPCs) when used at a concentration of 5 µM, an effect that can be reduced by inhibition of the antioxidative transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2). It increases phosphorylation of STAT3 and cyclin D1 and the protein levels of Nrf2 and heme oxygenase-1 (HO-1) in a concentration-dependent manner. Garcinone D (3 µM) inhibits aggregation of amyloid-β (1-42) (Aβ42; Item No. 20574) in vitro and inhibits beta-secretase 1 (BACE1) by 62.7% when used at a concentration of 100 µM.{54167} It scavenges peroxynitrite radicals with an IC50 value of 26.4 µM.{54168}  

     

    Brand:
    Cayman
    SKU:30906 - 5 mg

    Available on backorder

  • Gardiquimod is an agonist of human toll-like receptor 7 (TLR7), but not human TLR8, although it activates both porcine TLR7 and TLR8.{31200} At 0.5 to 2 µg/ml, it enhances the immunosuppressive activity of T regulatory cells.{31198} Gardiquimod is effective as a mucosal adjuvant for Norwalk virus-like particles and inhibits infection of macrophages and T cells by HIV-1.{31199,31197} It inhibits proliferation and migration while inducing apoptosis in pancreatic cancer cells in vitro.{31201}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Gardiquimod is an agonist of human toll-like receptor 7 (TLR7), but not human TLR8, although it activates both porcine TLR7 and TLR8.{31200} At 0.5 to 2 µg/ml, it enhances the immunosuppressive activity of T regulatory cells.{31198} Gardiquimod is effective as a mucosal adjuvant for Norwalk virus-like particles and inhibits infection of macrophages and T cells by HIV-1.{31199,31197} It inhibits proliferation and migration while inducing apoptosis in pancreatic cancer cells in vitro.{31201}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Gardiquimod is an agonist of human toll-like receptor 7 (TLR7), but not human TLR8, although it activates both porcine TLR7 and TLR8.{31200} At 0.5 to 2 µg/ml, it enhances the immunosuppressive activity of T regulatory cells.{31198} Gardiquimod is effective as a mucosal adjuvant for Norwalk virus-like particles and inhibits infection of macrophages and T cells by HIV-1.{31199,31197} It inhibits proliferation and migration while inducing apoptosis in pancreatic cancer cells in vitro.{31201}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Gardiquimod is an agonist of human toll-like receptor 7 (TLR7), but not human TLR8, although it activates both porcine TLR7 and TLR8.{31200} At 0.5 to 2 µg/ml, it enhances the immunosuppressive activity of T regulatory cells.{31198} Gardiquimod is effective as a mucosal adjuvant for Norwalk virus-like particles and inhibits infection of macrophages and T cells by HIV-1.{31199,31197} It inhibits proliferation and migration while inducing apoptosis in pancreatic cancer cells in vitro.{31201}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Gastrin I is an endogenous, gastrointestinal peptide hormone that binds to cholecystokinin (CCK) receptors on human gastric leiomyosarcoma cells (IC50 = 0.9 nM) and in guinea pig gallbladder and pancreatic tissue (IC50s = 1.7 and 2.5 μM, respectively).{36434,36435} It increases levels of cytosolic calcium in isolated rabbit stomach parietal cells (EC50 = 11 nM) and stimulates pepsinogen secretion by isolated human peptic cells (ED50 = 30 nM).{36436,36437} Gastrin I increases histidine decarboxylase (HDC) activity ex vivo in fundic stomach mucosa homogenate and increases gastric acid secretion in vivo in rats when administered at a dose of 1 nmol/kg/h.{36438}  

     

    Brand:
    Cayman
    SKU:24457 - 1 mg

    Available on backorder

  • Gastrodin is a phenolic glycoside that has been found in Gastrodia and has diverse biological activities.{46514,46515,46516,46517} It reduces cell death of rat hippocampal neurons and BV-2 mouse microglia induced by amyloid-β (1-42) (Aβ42; Item No. 20574) and improves learning and memory in various transgenic mouse models of Alzheimer’s disease.{46514} It reduces motor deficits and loss of dopaminergic neurons in a rat model of Parkinson’s disease induced by 6-OHDA (Item No. 25330). Gastrodin (50-200 mg/kg) reduces seizure duration and intensity in a rat model of pentylenetetrazole-kindling chronic epileptic seizures. In a mouse model of valproic acid-induced autistic-like phenotypes, gastrodin (100 mg/kg) increases social interaction and decreases marble burying and grooming behaviors, as well as restores inhibitory synaptic transmission and GAT1 and α5 subunit-containing GABAA expression in the basolateral amygdala.{46515} Gastrodin increases ultimate breaking force and bone stiffness, measures of biomechanical strength, in a rat model of osteoporosis induced by dexamethasone (Item No. 11015).{46516} It also inhibits ethanol-induced hepatocellular apoptosis and restores liver function in a rat model of alcoholic liver disease.{46517}  

     

    Brand:
    Cayman
    SKU:28828 - 100 mg

    Available on backorder

  • Gastrodin is a phenolic glycoside that has been found in Gastrodia and has diverse biological activities.{46514,46515,46516,46517} It reduces cell death of rat hippocampal neurons and BV-2 mouse microglia induced by amyloid-β (1-42) (Aβ42; Item No. 20574) and improves learning and memory in various transgenic mouse models of Alzheimer’s disease.{46514} It reduces motor deficits and loss of dopaminergic neurons in a rat model of Parkinson’s disease induced by 6-OHDA (Item No. 25330). Gastrodin (50-200 mg/kg) reduces seizure duration and intensity in a rat model of pentylenetetrazole-kindling chronic epileptic seizures. In a mouse model of valproic acid-induced autistic-like phenotypes, gastrodin (100 mg/kg) increases social interaction and decreases marble burying and grooming behaviors, as well as restores inhibitory synaptic transmission and GAT1 and α5 subunit-containing GABAA expression in the basolateral amygdala.{46515} Gastrodin increases ultimate breaking force and bone stiffness, measures of biomechanical strength, in a rat model of osteoporosis induced by dexamethasone (Item No. 11015).{46516} It also inhibits ethanol-induced hepatocellular apoptosis and restores liver function in a rat model of alcoholic liver disease.{46517}  

     

    Brand:
    Cayman
    SKU:28828 - 250 mg

    Available on backorder

  • Gastrodin is a phenolic glycoside that has been found in Gastrodia and has diverse biological activities.{46514,46515,46516,46517} It reduces cell death of rat hippocampal neurons and BV-2 mouse microglia induced by amyloid-β (1-42) (Aβ42; Item No. 20574) and improves learning and memory in various transgenic mouse models of Alzheimer’s disease.{46514} It reduces motor deficits and loss of dopaminergic neurons in a rat model of Parkinson’s disease induced by 6-OHDA (Item No. 25330). Gastrodin (50-200 mg/kg) reduces seizure duration and intensity in a rat model of pentylenetetrazole-kindling chronic epileptic seizures. In a mouse model of valproic acid-induced autistic-like phenotypes, gastrodin (100 mg/kg) increases social interaction and decreases marble burying and grooming behaviors, as well as restores inhibitory synaptic transmission and GAT1 and α5 subunit-containing GABAA expression in the basolateral amygdala.{46515} Gastrodin increases ultimate breaking force and bone stiffness, measures of biomechanical strength, in a rat model of osteoporosis induced by dexamethasone (Item No. 11015).{46516} It also inhibits ethanol-induced hepatocellular apoptosis and restores liver function in a rat model of alcoholic liver disease.{46517}  

     

    Brand:
    Cayman
    SKU:28828 - 50 mg

    Available on backorder

  • Gastrodin is a phenolic glycoside that has been found in Gastrodia and has diverse biological activities.{46514,46515,46516,46517} It reduces cell death of rat hippocampal neurons and BV-2 mouse microglia induced by amyloid-β (1-42) (Aβ42; Item No. 20574) and improves learning and memory in various transgenic mouse models of Alzheimer’s disease.{46514} It reduces motor deficits and loss of dopaminergic neurons in a rat model of Parkinson’s disease induced by 6-OHDA (Item No. 25330). Gastrodin (50-200 mg/kg) reduces seizure duration and intensity in a rat model of pentylenetetrazole-kindling chronic epileptic seizures. In a mouse model of valproic acid-induced autistic-like phenotypes, gastrodin (100 mg/kg) increases social interaction and decreases marble burying and grooming behaviors, as well as restores inhibitory synaptic transmission and GAT1 and α5 subunit-containing GABAA expression in the basolateral amygdala.{46515} Gastrodin increases ultimate breaking force and bone stiffness, measures of biomechanical strength, in a rat model of osteoporosis induced by dexamethasone (Item No. 11015).{46516} It also inhibits ethanol-induced hepatocellular apoptosis and restores liver function in a rat model of alcoholic liver disease.{46517}  

     

    Brand:
    Cayman
    SKU:28828 - 500 mg

    Available on backorder

  • GAT211 is an agonist and positive allosteric modulator (PAM) of cannabinoid receptor 1 (CB1) and a racemic mixture of GAT228 (Item No. 24485) and GAT229 (Item No. 24486), which have enantiomer-specific activities.{35179} GAT211 increases β-arrestin recruitment and cAMP inhibition in HEK293A cells expressing GFP-tagged human CB1 (hCB1-GFP) in a concentration-dependent manner. It also enhances the binding of the CB1 full agonist CP 55,940 to CHO cells expressing hCB1, as well as the activity of 2-arachidonoyl glycerol (2-AG; Item No. 62160), arachidonoyl ethanolamide (AEA; Item No. 90050), and CP 55,940 in arrestin2 recruitment assays and increases ERK1/2 and PLCβ3 phosphorylation in HEK293 cells expressing hCB1. It inhibits excitatory postsynaptic currents (EPSCs) in a subset of CB1-expressing murine autaptic hippocampal neurons when used at a concentration of 1 µM.{48089} GAT211 also decreases mechanical hypersensitivity in wild-type (EC50 = 9.75 mg/kg), but not CB1 knockout, mice in a model of inflammatory pain induced by complete Freund’s adjuvant (CFA), and decreases mechanical and cold allodynia in a mouse model of paclitaxel-induced neuropathic pain when used at doses of 10 and 20 mg/kg per day.{47206}  

     

    Brand:
    Cayman
    SKU:24484 - 1 mg

    Available on backorder

  • GAT211 is an agonist and positive allosteric modulator (PAM) of cannabinoid receptor 1 (CB1) and a racemic mixture of GAT228 (Item No. 24485) and GAT229 (Item No. 24486), which have enantiomer-specific activities.{35179} GAT211 increases β-arrestin recruitment and cAMP inhibition in HEK293A cells expressing GFP-tagged human CB1 (hCB1-GFP) in a concentration-dependent manner. It also enhances the binding of the CB1 full agonist CP 55,940 to CHO cells expressing hCB1, as well as the activity of 2-arachidonoyl glycerol (2-AG; Item No. 62160), arachidonoyl ethanolamide (AEA; Item No. 90050), and CP 55,940 in arrestin2 recruitment assays and increases ERK1/2 and PLCβ3 phosphorylation in HEK293 cells expressing hCB1. It inhibits excitatory postsynaptic currents (EPSCs) in a subset of CB1-expressing murine autaptic hippocampal neurons when used at a concentration of 1 µM.{48089} GAT211 also decreases mechanical hypersensitivity in wild-type (EC50 = 9.75 mg/kg), but not CB1 knockout, mice in a model of inflammatory pain induced by complete Freund’s adjuvant (CFA), and decreases mechanical and cold allodynia in a mouse model of paclitaxel-induced neuropathic pain when used at doses of 10 and 20 mg/kg per day.{47206}  

     

    Brand:
    Cayman
    SKU:24484 - 5 mg

    Available on backorder

  • GAT228 is an allosteric agonist of cannabinoid receptor 1 (CB1), the R-(+)-enantiomer of the CB1 positive allosteric modulator (PAM) GAT229 (Item No. 24486), and a component of the racemic mixture GAT211, which acts as both an agonist and PAM.{35179,48089} GAT228 increases β-arrestin recruitment, cAMP inhibition, and ERK1/2 and PLCβ3 phosphorylation in HEK293A cells expressing GFP-tagged human CB1 (hCB1-GFP) in a concentration-dependent manner.{35179} Unlike GAT229, GAT228 has no effect on the binding of the CB receptor agonist CP 55,940 to membranes from CHO cells expressing hCB1 when used at concentrations up to 1 µM. It inhibits excitatory postsynaptic currents (EPSCs) in a subset of CB1-expressing murine autaptic hippocampal neurons when used at a concentration of 1 µM.{48089}  

     

    Brand:
    Cayman
    SKU:24485 - 1 mg

    Available on backorder

  • GAT228 is an allosteric agonist of cannabinoid receptor 1 (CB1), the R-(+)-enantiomer of the CB1 positive allosteric modulator (PAM) GAT229 (Item No. 24486), and a component of the racemic mixture GAT211, which acts as both an agonist and PAM.{35179,48089} GAT228 increases β-arrestin recruitment, cAMP inhibition, and ERK1/2 and PLCβ3 phosphorylation in HEK293A cells expressing GFP-tagged human CB1 (hCB1-GFP) in a concentration-dependent manner.{35179} Unlike GAT229, GAT228 has no effect on the binding of the CB receptor agonist CP 55,940 to membranes from CHO cells expressing hCB1 when used at concentrations up to 1 µM. It inhibits excitatory postsynaptic currents (EPSCs) in a subset of CB1-expressing murine autaptic hippocampal neurons when used at a concentration of 1 µM.{48089}  

     

    Brand:
    Cayman
    SKU:24485 - 10 mg

    Available on backorder

  • GAT228 is an allosteric agonist of cannabinoid receptor 1 (CB1), the R-(+)-enantiomer of the CB1 positive allosteric modulator (PAM) GAT229 (Item No. 24486), and a component of the racemic mixture GAT211, which acts as both an agonist and PAM.{35179,48089} GAT228 increases β-arrestin recruitment, cAMP inhibition, and ERK1/2 and PLCβ3 phosphorylation in HEK293A cells expressing GFP-tagged human CB1 (hCB1-GFP) in a concentration-dependent manner.{35179} Unlike GAT229, GAT228 has no effect on the binding of the CB receptor agonist CP 55,940 to membranes from CHO cells expressing hCB1 when used at concentrations up to 1 µM. It inhibits excitatory postsynaptic currents (EPSCs) in a subset of CB1-expressing murine autaptic hippocampal neurons when used at a concentration of 1 µM.{48089}  

     

    Brand:
    Cayman
    SKU:24485 - 5 mg

    Available on backorder

  • GAT229 is a positive allosteric modulator of cannabinoid receptor 1 (CB1) and the S-(–) enantiomer of the CB1 modulator GAT211.{35179,48089} It does not activate the receptor on its own but enhances the binding and activity of CB agonists. GAT229 (1 µM) enhances the binding of the CB1 full agonist CP 55,940 to CHO cells expressing human recombinant CB1 (hCB1), as well as the activity of 2-arachidonoyl glycerol (2-AG; Item No. 62160), arachidonoyl ethanolamide (AEA; Item No. 90050), and CP 55,940 in arrestin2 recruitment assays and increases ERK1/2 and PLCβ3 phosphorylation in HEK293 cells expressing hCB1. GAT229 (1 μM) enhances depolarization-induced suppression of excitation but does not inhibit excitatory postsynaptic currents (EPSCs) in murine autaptic hippocampal neurons.{48089} GAT229 (0.2%, topical) reduces intraocular pressure by 5.8 and 7.7 mm Hg after 6 and 12 hours, respectively, in a transgenic mouse model of ocular hypertension using nose, ear, eye mutation (nee) mice.{48090}  

     

    Brand:
    Cayman
    SKU:24486 - 1 mg

    Available on backorder

  • GAT229 is a positive allosteric modulator of cannabinoid receptor 1 (CB1) and the S-(–) enantiomer of the CB1 modulator GAT211.{35179,48089} It does not activate the receptor on its own but enhances the binding and activity of CB agonists. GAT229 (1 µM) enhances the binding of the CB1 full agonist CP 55,940 to CHO cells expressing human recombinant CB1 (hCB1), as well as the activity of 2-arachidonoyl glycerol (2-AG; Item No. 62160), arachidonoyl ethanolamide (AEA; Item No. 90050), and CP 55,940 in arrestin2 recruitment assays and increases ERK1/2 and PLCβ3 phosphorylation in HEK293 cells expressing hCB1. GAT229 (1 μM) enhances depolarization-induced suppression of excitation but does not inhibit excitatory postsynaptic currents (EPSCs) in murine autaptic hippocampal neurons.{48089} GAT229 (0.2%, topical) reduces intraocular pressure by 5.8 and 7.7 mm Hg after 6 and 12 hours, respectively, in a transgenic mouse model of ocular hypertension using nose, ear, eye mutation (nee) mice.{48090}  

     

    Brand:
    Cayman
    SKU:24486 - 10 mg

    Available on backorder

  • GAT229 is a positive allosteric modulator of cannabinoid receptor 1 (CB1) and the S-(–) enantiomer of the CB1 modulator GAT211.{35179,48089} It does not activate the receptor on its own but enhances the binding and activity of CB agonists. GAT229 (1 µM) enhances the binding of the CB1 full agonist CP 55,940 to CHO cells expressing human recombinant CB1 (hCB1), as well as the activity of 2-arachidonoyl glycerol (2-AG; Item No. 62160), arachidonoyl ethanolamide (AEA; Item No. 90050), and CP 55,940 in arrestin2 recruitment assays and increases ERK1/2 and PLCβ3 phosphorylation in HEK293 cells expressing hCB1. GAT229 (1 μM) enhances depolarization-induced suppression of excitation but does not inhibit excitatory postsynaptic currents (EPSCs) in murine autaptic hippocampal neurons.{48089} GAT229 (0.2%, topical) reduces intraocular pressure by 5.8 and 7.7 mm Hg after 6 and 12 hours, respectively, in a transgenic mouse model of ocular hypertension using nose, ear, eye mutation (nee) mice.{48090}  

     

    Brand:
    Cayman
    SKU:24486 - 5 mg

    Available on backorder

  • Gatifloxacin is a fluoroquinolone antibiotic which inhibits bacterial DNA gyrase (IC50 = 0.109 μg/ml) and topoisomerase IV (IC50 = 13.8 μg/ml).{22453} It is much less effective against HeLa cell topoisomerase II (IC50 = 265 μg/ml).{22453} Gatifloxin has been used as a broad-spectrum oral antibiotic, but it can produce dysglycemia in older adults.{22452} It remains useful for resolving bacterial conjunctivitis.{22451}  

     

    Brand:
    Cayman
    SKU:-
  • Gatifloxacin is a fluoroquinolone antibiotic which inhibits bacterial DNA gyrase (IC50 = 0.109 μg/ml) and topoisomerase IV (IC50 = 13.8 μg/ml).{22453} It is much less effective against HeLa cell topoisomerase II (IC50 = 265 μg/ml).{22453} Gatifloxin has been used as a broad-spectrum oral antibiotic, but it can produce dysglycemia in older adults.{22452} It remains useful for resolving bacterial conjunctivitis.{22451}  

     

    Brand:
    Cayman
    SKU:-
  • Gatifloxacin is a fluoroquinolone antibiotic which inhibits bacterial DNA gyrase (IC50 = 0.109 μg/ml) and topoisomerase IV (IC50 = 13.8 μg/ml).{22453} It is much less effective against HeLa cell topoisomerase II (IC50 = 265 μg/ml).{22453} Gatifloxin has been used as a broad-spectrum oral antibiotic, but it can produce dysglycemia in older adults.{22452} It remains useful for resolving bacterial conjunctivitis.{22451}  

     

    Brand:
    Cayman
    SKU:-
  • Gboxin is an inhibitor of oxidative phosphorylation in cancer cells, which have a higher mitochondrial proton gradient and pH compared with non-cancerous cells.{35805} It increases the mitochondrial membrane potential and reduces the oxygen consumption rate, which can be bypassed by the proton ionophore FCCP (Item No. 15218), indicating that it inhibits F0F1 ATP synthase/complex V. Gboxin decreases viability of three primary mouse glioblastoma cell lines (IC50s = ~150 nM) and three patient-derived glioblastoma cultures (IC50s = ~1 µM) but does not affect the viability of primary mouse embryonic fibroblasts or astrocytes. It halts the cell cycle in the G1/G0 phase and induces apoptosis of primary low-passage glioblastoma cells pooled from multiple tumors.  

     

    Brand:
    Cayman
    SKU:27861 - 1 mg

    Available on backorder

  • Gboxin is an inhibitor of oxidative phosphorylation in cancer cells, which have a higher mitochondrial proton gradient and pH compared with non-cancerous cells.{35805} It increases the mitochondrial membrane potential and reduces the oxygen consumption rate, which can be bypassed by the proton ionophore FCCP (Item No. 15218), indicating that it inhibits F0F1 ATP synthase/complex V. Gboxin decreases viability of three primary mouse glioblastoma cell lines (IC50s = ~150 nM) and three patient-derived glioblastoma cultures (IC50s = ~1 µM) but does not affect the viability of primary mouse embryonic fibroblasts or astrocytes. It halts the cell cycle in the G1/G0 phase and induces apoptosis of primary low-passage glioblastoma cells pooled from multiple tumors.  

     

    Brand:
    Cayman
    SKU:27861 - 10 mg

    Available on backorder

  • Gboxin is an inhibitor of oxidative phosphorylation in cancer cells, which have a higher mitochondrial proton gradient and pH compared with non-cancerous cells.{35805} It increases the mitochondrial membrane potential and reduces the oxygen consumption rate, which can be bypassed by the proton ionophore FCCP (Item No. 15218), indicating that it inhibits F0F1 ATP synthase/complex V. Gboxin decreases viability of three primary mouse glioblastoma cell lines (IC50s = ~150 nM) and three patient-derived glioblastoma cultures (IC50s = ~1 µM) but does not affect the viability of primary mouse embryonic fibroblasts or astrocytes. It halts the cell cycle in the G1/G0 phase and induces apoptosis of primary low-passage glioblastoma cells pooled from multiple tumors.  

     

    Brand:
    Cayman
    SKU:27861 - 5 mg

    Available on backorder

  • GBR 12909 is a potent inhibitor that blocks dopamine uptake (IC50 = 1-51 nM).{25553,25555} It is more than 100-fold less effective at blocking serotonin or noradrenaline uptake.{25553,25555} GBR 12909 effectively inhibits dopamine uptake in vivo, leading to consequent stimulation of dopamine receptors.{25553,25554} GBR 12909 also inhibits pyrilamine binding to the histamine H1 receptor (IC50 = 18 nM) but poorly inhibits ligand binding to dopamine, adrenergic, acetylcholine, serotonin, and γ-aminobutyric acid receptors.{25555} It also blocks ligand binding to sigma receptors in rat brain (IC50 = 48 nM).{25552}  

     

    Brand:
    Cayman
    SKU:-
  • GBR 12909 is a potent inhibitor that blocks dopamine uptake (IC50 = 1-51 nM).{25553,25555} It is more than 100-fold less effective at blocking serotonin or noradrenaline uptake.{25553,25555} GBR 12909 effectively inhibits dopamine uptake in vivo, leading to consequent stimulation of dopamine receptors.{25553,25554} GBR 12909 also inhibits pyrilamine binding to the histamine H1 receptor (IC50 = 18 nM) but poorly inhibits ligand binding to dopamine, adrenergic, acetylcholine, serotonin, and γ-aminobutyric acid receptors.{25555} It also blocks ligand binding to sigma receptors in rat brain (IC50 = 48 nM).{25552}  

     

    Brand:
    Cayman
    SKU:-
  • GBR 12909 is a potent inhibitor that blocks dopamine uptake (IC50 = 1-51 nM).{25553,25555} It is more than 100-fold less effective at blocking serotonin or noradrenaline uptake.{25553,25555} GBR 12909 effectively inhibits dopamine uptake in vivo, leading to consequent stimulation of dopamine receptors.{25553,25554} GBR 12909 also inhibits pyrilamine binding to the histamine H1 receptor (IC50 = 18 nM) but poorly inhibits ligand binding to dopamine, adrenergic, acetylcholine, serotonin, and γ-aminobutyric acid receptors.{25555} It also blocks ligand binding to sigma receptors in rat brain (IC50 = 48 nM).{25552}  

     

    Brand:
    Cayman
    SKU:-
  • GBR 12909 is a potent inhibitor that blocks dopamine uptake (IC50 = 1-51 nM).{25553,25555} It is more than 100-fold less effective at blocking serotonin or noradrenaline uptake.{25553,25555} GBR 12909 effectively inhibits dopamine uptake in vivo, leading to consequent stimulation of dopamine receptors.{25553,25554} GBR 12909 also inhibits pyrilamine binding to the histamine H1 receptor (IC50 = 18 nM) but poorly inhibits ligand binding to dopamine, adrenergic, acetylcholine, serotonin, and γ-aminobutyric acid receptors.{25555} It also blocks ligand binding to sigma receptors in rat brain (IC50 = 48 nM).{25552}  

     

    Brand:
    Cayman
    SKU:-
  • GBR 12935 is an inhibitor of dopamine uptake that binds to the dopamine transporter (Kd = 27.2 nM).{22877,36625} It is selective for the dopamine transporter over the serotonin and norepinephrine transporters (Kds = 940 and 310 nM, respectively).{22877} In mice, it increases locomotor activity, but not stereotypic behavior, when administered at a dose of 10 mg/kg but induces gnawing at levels similar to other indirect dopamine agonists with an ED50 value of 17.1 mg/kg.{36625,36626}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • GBR 12935 is an inhibitor of dopamine uptake that binds to the dopamine transporter (Kd = 27.2 nM).{22877,36625} It is selective for the dopamine transporter over the serotonin and norepinephrine transporters (Kds = 940 and 310 nM, respectively).{22877} In mice, it increases locomotor activity, but not stereotypic behavior, when administered at a dose of 10 mg/kg but induces gnawing at levels similar to other indirect dopamine agonists with an ED50 value of 17.1 mg/kg.{36625,36626}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • GBR 12935 is an inhibitor of dopamine uptake that binds to the dopamine transporter (Kd = 27.2 nM).{22877,36625} It is selective for the dopamine transporter over the serotonin and norepinephrine transporters (Kds = 940 and 310 nM, respectively).{22877} In mice, it increases locomotor activity, but not stereotypic behavior, when administered at a dose of 10 mg/kg but induces gnawing at levels similar to other indirect dopamine agonists with an ED50 value of 17.1 mg/kg.{36625,36626}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • GBR 12935 is an inhibitor of dopamine uptake that binds to the dopamine transporter (Kd = 27.2 nM).{22877,36625} It is selective for the dopamine transporter over the serotonin and norepinephrine transporters (Kds = 940 and 310 nM, respectively).{22877} In mice, it increases locomotor activity, but not stereotypic behavior, when administered at a dose of 10 mg/kg but induces gnawing at levels similar to other indirect dopamine agonists with an ED50 value of 17.1 mg/kg.{36625,36626}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • GBT-440 is a modulator of sickle hemoglobin (HbS) that binds covalently to the N-terminal valine of the α chain of HbS.{41378} In vitro, GBT-440 increases HbS affinity for oxygen (EC50s = 8.2 and 415 μM for purified HbS and whole blood from sickle cell anemia patients, respectively) and delays oxygen release from and polymerization of HbS in a concentration-dependent manner. GBT-440 (100-150 mg/kg) increases red blood cell half-life and reduces sickling ex vivo in whole blood isolated from a murine model of sickle cell anemia. It also reduces ex vivo sickling of sickle cell trait red blood cells under conditions of hypoxia, acidosis, and dehydration.{41379}  

     

    Brand:
    Cayman
    SKU:23933 - 1 mg

    Available on backorder

  • GBT-440 is a modulator of sickle hemoglobin (HbS) that binds covalently to the N-terminal valine of the α chain of HbS.{41378} In vitro, GBT-440 increases HbS affinity for oxygen (EC50s = 8.2 and 415 μM for purified HbS and whole blood from sickle cell anemia patients, respectively) and delays oxygen release from and polymerization of HbS in a concentration-dependent manner. GBT-440 (100-150 mg/kg) increases red blood cell half-life and reduces sickling ex vivo in whole blood isolated from a murine model of sickle cell anemia. It also reduces ex vivo sickling of sickle cell trait red blood cells under conditions of hypoxia, acidosis, and dehydration.{41379}  

     

    Brand:
    Cayman
    SKU:23933 - 10 mg

    Available on backorder

  • GBT-440 is a modulator of sickle hemoglobin (HbS) that binds covalently to the N-terminal valine of the α chain of HbS.{41378} In vitro, GBT-440 increases HbS affinity for oxygen (EC50s = 8.2 and 415 μM for purified HbS and whole blood from sickle cell anemia patients, respectively) and delays oxygen release from and polymerization of HbS in a concentration-dependent manner. GBT-440 (100-150 mg/kg) increases red blood cell half-life and reduces sickling ex vivo in whole blood isolated from a murine model of sickle cell anemia. It also reduces ex vivo sickling of sickle cell trait red blood cells under conditions of hypoxia, acidosis, and dehydration.{41379}  

     

    Brand:
    Cayman
    SKU:23933 - 25 mg

    Available on backorder

  • GBT-440 is a modulator of sickle hemoglobin (HbS) that binds covalently to the N-terminal valine of the α chain of HbS.{41378} In vitro, GBT-440 increases HbS affinity for oxygen (EC50s = 8.2 and 415 μM for purified HbS and whole blood from sickle cell anemia patients, respectively) and delays oxygen release from and polymerization of HbS in a concentration-dependent manner. GBT-440 (100-150 mg/kg) increases red blood cell half-life and reduces sickling ex vivo in whole blood isolated from a murine model of sickle cell anemia. It also reduces ex vivo sickling of sickle cell trait red blood cells under conditions of hypoxia, acidosis, and dehydration.{41379}  

     

    Brand:
    Cayman
    SKU:23933 - 5 mg

    Available on backorder

  • [Bertin Catalog No. G01045]  

     

    Brand:
    Cayman
    SKU:32901 - 100 µl

    Available on backorder

  • Host: Mouse • Applications: ELISA, IF, IP, WB  

     

    Brand:
    Cayman
    SKU:32901- 100 µl

    Available on backorder

  • Host: Mouse • Applications: ELISA, IF, IP, WB  

     

    Brand:
    Cayman
    SKU:32901- 100 µl
  • GDC 0879 is an inhibitor of B-RafV600E (IC50 = 0.13 nM for human recombinant enzyme).{27943} It is selective for B-RafV600E over a panel of 140 kinases at a concentration of 1 μM. GDC 0879 inhibits phosphorylation of ERK in MALME-3M cells (IC50 = 63 nM) as well as phosphorylation of MEK1 in COLO 205 and A375 cells that express B-RafV600E (IC50s = 29 and 59 nM, respectively). In vivo, GDC 0879 (15-200 mg/kg) inhibits tumor growth in a dose-dependent manner in an A375 mouse xenograft model.  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • GDC 0879 is an inhibitor of B-RafV600E (IC50 = 0.13 nM for human recombinant enzyme).{27943} It is selective for B-RafV600E over a panel of 140 kinases at a concentration of 1 μM. GDC 0879 inhibits phosphorylation of ERK in MALME-3M cells (IC50 = 63 nM) as well as phosphorylation of MEK1 in COLO 205 and A375 cells that express B-RafV600E (IC50s = 29 and 59 nM, respectively). In vivo, GDC 0879 (15-200 mg/kg) inhibits tumor growth in a dose-dependent manner in an A375 mouse xenograft model.  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • GDC 0879 is an inhibitor of B-RafV600E (IC50 = 0.13 nM for human recombinant enzyme).{27943} It is selective for B-RafV600E over a panel of 140 kinases at a concentration of 1 μM. GDC 0879 inhibits phosphorylation of ERK in MALME-3M cells (IC50 = 63 nM) as well as phosphorylation of MEK1 in COLO 205 and A375 cells that express B-RafV600E (IC50s = 29 and 59 nM, respectively). In vivo, GDC 0879 (15-200 mg/kg) inhibits tumor growth in a dose-dependent manner in an A375 mouse xenograft model.  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • GDC 0879 is an inhibitor of B-RafV600E (IC50 = 0.13 nM for human recombinant enzyme).{27943} It is selective for B-RafV600E over a panel of 140 kinases at a concentration of 1 μM. GDC 0879 inhibits phosphorylation of ERK in MALME-3M cells (IC50 = 63 nM) as well as phosphorylation of MEK1 in COLO 205 and A375 cells that express B-RafV600E (IC50s = 29 and 59 nM, respectively). In vivo, GDC 0879 (15-200 mg/kg) inhibits tumor growth in a dose-dependent manner in an A375 mouse xenograft model.  

     

    Brand:
    Cayman
    SKU:-

    Out of stock

  • GDC-0032 is a potent inhibitor of phosphatidylinositol 3-kinase (PI3K) isoforms α, δ, and γ (IC50s = 0.28, 0.12, and 0.97 nM, respectively) that is 31 times less potent at PI3Kβ.{31881} It is over 1,000-fold selective for p100α over other PI3K-like kinases, including DNA-dependent protein kinase catalytic subunits, ATM, and ATR. GDC-0032 has increased potency in cancer cell lines harboring PIK3CA-activating alterations, and is effective in vivo, suppressing the growth of tumors in a mouse xenograft model at low drug dose levels.{31880,31881,31882}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • GDC-0032 is a potent inhibitor of phosphatidylinositol 3-kinase (PI3K) isoforms α, δ, and γ (IC50s = 0.28, 0.12, and 0.97 nM, respectively) that is 31 times less potent at PI3Kβ.{31881} It is over 1,000-fold selective for p100α over other PI3K-like kinases, including DNA-dependent protein kinase catalytic subunits, ATM, and ATR. GDC-0032 has increased potency in cancer cell lines harboring PIK3CA-activating alterations, and is effective in vivo, suppressing the growth of tumors in a mouse xenograft model at low drug dose levels.{31880,31881,31882}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • GDC-0032 is a potent inhibitor of phosphatidylinositol 3-kinase (PI3K) isoforms α, δ, and γ (IC50s = 0.28, 0.12, and 0.97 nM, respectively) that is 31 times less potent at PI3Kβ.{31881} It is over 1,000-fold selective for p100α over other PI3K-like kinases, including DNA-dependent protein kinase catalytic subunits, ATM, and ATR. GDC-0032 has increased potency in cancer cell lines harboring PIK3CA-activating alterations, and is effective in vivo, suppressing the growth of tumors in a mouse xenograft model at low drug dose levels.{31880,31881,31882}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • GDC-0068 is a selective, ATP-competitive, pan-Akt inhibitor that targets Akt1, 2, and 3 with IC50 values of 5, 18, and 8 nM, respectively in cell-free assays.{30936} It is 620-fold selective for Akt over protein kinase A and has been shown to block Akt signaling selectively in cultured tumor cell lines characterized by activated Akt, halting cell cycle progression and reducing cell viability.{30936} In multiple tumor xenograft models, oral administration of GDC-0068 at 100 mg/kg/day can lead to delayed tumor growth and regression.{30936}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • GDC-0068 is a selective, ATP-competitive, pan-Akt inhibitor that targets Akt1, 2, and 3 with IC50 values of 5, 18, and 8 nM, respectively in cell-free assays.{30936} It is 620-fold selective for Akt over protein kinase A and has been shown to block Akt signaling selectively in cultured tumor cell lines characterized by activated Akt, halting cell cycle progression and reducing cell viability.{30936} In multiple tumor xenograft models, oral administration of GDC-0068 at 100 mg/kg/day can lead to delayed tumor growth and regression.{30936}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • GDC-0068 is a selective, ATP-competitive, pan-Akt inhibitor that targets Akt1, 2, and 3 with IC50 values of 5, 18, and 8 nM, respectively in cell-free assays.{30936} It is 620-fold selective for Akt over protein kinase A and has been shown to block Akt signaling selectively in cultured tumor cell lines characterized by activated Akt, halting cell cycle progression and reducing cell viability.{30936} In multiple tumor xenograft models, oral administration of GDC-0068 at 100 mg/kg/day can lead to delayed tumor growth and regression.{30936}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • GDC-0068 is a selective, ATP-competitive, pan-Akt inhibitor that targets Akt1, 2, and 3 with IC50 values of 5, 18, and 8 nM, respectively in cell-free assays.{30936} It is 620-fold selective for Akt over protein kinase A and has been shown to block Akt signaling selectively in cultured tumor cell lines characterized by activated Akt, halting cell cycle progression and reducing cell viability.{30936} In multiple tumor xenograft models, oral administration of GDC-0068 at 100 mg/kg/day can lead to delayed tumor growth and regression.{30936}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • GDC-0084 is a dual inhibitor of phosphatidylinositol 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR) with Kiapp values of 2, 46, 3, 10, and 70 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ, and mTOR, respectively.{45137} It inhibits the proliferation of PC3 cells in vitro (EC50 = 0.4 μM). GDC-0084 (25 mg/kg) reduces phosphorylation of Akt in mouse brain. It reduces tumor growth in a U87 MG/M human glioblastoma mouse xenograft model when administered at doses greater than 2.2 mg/kg and induces tumor regression when administered at a dose of 17.9 mg/kg. GDC-0084 (25 and 50 mg/kg) also reduces tumor growth in an A431 cutaneous squamous cell carcinoma (cSCC) mouse xenograft model.{45138}  

     

    Brand:
    Cayman
    SKU:26390 - 1 mg

    Available on backorder

  • GDC-0084 is a dual inhibitor of phosphatidylinositol 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR) with Kiapp values of 2, 46, 3, 10, and 70 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ, and mTOR, respectively.{45137} It inhibits the proliferation of PC3 cells in vitro (EC50 = 0.4 μM). GDC-0084 (25 mg/kg) reduces phosphorylation of Akt in mouse brain. It reduces tumor growth in a U87 MG/M human glioblastoma mouse xenograft model when administered at doses greater than 2.2 mg/kg and induces tumor regression when administered at a dose of 17.9 mg/kg. GDC-0084 (25 and 50 mg/kg) also reduces tumor growth in an A431 cutaneous squamous cell carcinoma (cSCC) mouse xenograft model.{45138}  

     

    Brand:
    Cayman
    SKU:26390 - 10 mg

    Available on backorder

  • GDC-0084 is a dual inhibitor of phosphatidylinositol 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR) with Kiapp values of 2, 46, 3, 10, and 70 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ, and mTOR, respectively.{45137} It inhibits the proliferation of PC3 cells in vitro (EC50 = 0.4 μM). GDC-0084 (25 mg/kg) reduces phosphorylation of Akt in mouse brain. It reduces tumor growth in a U87 MG/M human glioblastoma mouse xenograft model when administered at doses greater than 2.2 mg/kg and induces tumor regression when administered at a dose of 17.9 mg/kg. GDC-0084 (25 and 50 mg/kg) also reduces tumor growth in an A431 cutaneous squamous cell carcinoma (cSCC) mouse xenograft model.{45138}  

     

    Brand:
    Cayman
    SKU:26390 - 25 mg

    Available on backorder

  • GDC-0084 is a dual inhibitor of phosphatidylinositol 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR) with Kiapp values of 2, 46, 3, 10, and 70 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ, and mTOR, respectively.{45137} It inhibits the proliferation of PC3 cells in vitro (EC50 = 0.4 μM). GDC-0084 (25 mg/kg) reduces phosphorylation of Akt in mouse brain. It reduces tumor growth in a U87 MG/M human glioblastoma mouse xenograft model when administered at doses greater than 2.2 mg/kg and induces tumor regression when administered at a dose of 17.9 mg/kg. GDC-0084 (25 and 50 mg/kg) also reduces tumor growth in an A431 cutaneous squamous cell carcinoma (cSCC) mouse xenograft model.{45138}  

     

    Brand:
    Cayman
    SKU:26390 - 5 mg

    Available on backorder

  • Inhibitor of apoptosis proteins (IAPs), which block various signaling pathways leading to apoptotic cell death, are commonly over-expressed in cancer cells.{9448} GDC-0152 is a potent inhibitor of specific IAPs that binds baculoviral IAP repeat (BIR) domains (Kis = 28, 14, 17, and 43 nM for XIAP BIR3, NL-IAP BIR, BIRC2 (c-IAP1) BIR3, and BIRC3 (c-IAP2) BIR3, respectively).{29254} GDC-0152 induces activation of caspases, decreasing the viability of cancer cells without affecting normal cells.{29254,29255} It is orally bioavailable and suppresses tumor growth in breast cancer xenografts in mice.{29254} GDC-0152 also induces NF-κB transcriptional activity, resulting in the expression of several cytokines, including TNF-α.{29253} In dogs and rats, but not humans, this leads to a pronounced inflammatory response.{29253}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Inhibitor of apoptosis proteins (IAPs), which block various signaling pathways leading to apoptotic cell death, are commonly over-expressed in cancer cells.{9448} GDC-0152 is a potent inhibitor of specific IAPs that binds baculoviral IAP repeat (BIR) domains (Kis = 28, 14, 17, and 43 nM for XIAP BIR3, NL-IAP BIR, BIRC2 (c-IAP1) BIR3, and BIRC3 (c-IAP2) BIR3, respectively).{29254} GDC-0152 induces activation of caspases, decreasing the viability of cancer cells without affecting normal cells.{29254,29255} It is orally bioavailable and suppresses tumor growth in breast cancer xenografts in mice.{29254} GDC-0152 also induces NF-κB transcriptional activity, resulting in the expression of several cytokines, including TNF-α.{29253} In dogs and rats, but not humans, this leads to a pronounced inflammatory response.{29253}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • Inhibitor of apoptosis proteins (IAPs), which block various signaling pathways leading to apoptotic cell death, are commonly over-expressed in cancer cells.{9448} GDC-0152 is a potent inhibitor of specific IAPs that binds baculoviral IAP repeat (BIR) domains (Kis = 28, 14, 17, and 43 nM for XIAP BIR3, NL-IAP BIR, BIRC2 (c-IAP1) BIR3, and BIRC3 (c-IAP2) BIR3, respectively).{29254} GDC-0152 induces activation of caspases, decreasing the viability of cancer cells without affecting normal cells.{29254,29255} It is orally bioavailable and suppresses tumor growth in breast cancer xenografts in mice.{29254} GDC-0152 also induces NF-κB transcriptional activity, resulting in the expression of several cytokines, including TNF-α.{29253} In dogs and rats, but not humans, this leads to a pronounced inflammatory response.{29253}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • GDC-0326 is an inhibitor of phosphatidylinositol 3-kinase α (PI3Kα; Ki = 0.2 nM) that is 133-, 20-, and 51-fold selective for PI3Kα over PI3Kβ, PI3Kδ, and PI3Kγ, respectively.{43203} It inhibits proliferation of MCF7-neo/HER2 and PC3 cells (EC50s = 0.1 and 2.2 μM, respectively). In vivo, GDC-0326 (6.25 mg/kg) induces tumor regression in a KPL-4 mouse xenograft model. It also reduces tumor growth, tumor vasculature, and the number of liver and lymph node metastases in the RIP1-Tag2 transgenic mouse model of pancreatic neuroendocrine tumors.{43204}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • GDC-0326 is an inhibitor of phosphatidylinositol 3-kinase α (PI3Kα; Ki = 0.2 nM) that is 133-, 20-, and 51-fold selective for PI3Kα over PI3Kβ, PI3Kδ, and PI3Kγ, respectively.{43203} It inhibits proliferation of MCF7-neo/HER2 and PC3 cells (EC50s = 0.1 and 2.2 μM, respectively). In vivo, GDC-0326 (6.25 mg/kg) induces tumor regression in a KPL-4 mouse xenograft model. It also reduces tumor growth, tumor vasculature, and the number of liver and lymph node metastases in the RIP1-Tag2 transgenic mouse model of pancreatic neuroendocrine tumors.{43204}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • GDC-0326 is an inhibitor of phosphatidylinositol 3-kinase α (PI3Kα; Ki = 0.2 nM) that is 133-, 20-, and 51-fold selective for PI3Kα over PI3Kβ, PI3Kδ, and PI3Kγ, respectively.{43203} It inhibits proliferation of MCF7-neo/HER2 and PC3 cells (EC50s = 0.1 and 2.2 μM, respectively). In vivo, GDC-0326 (6.25 mg/kg) induces tumor regression in a KPL-4 mouse xenograft model. It also reduces tumor growth, tumor vasculature, and the number of liver and lymph node metastases in the RIP1-Tag2 transgenic mouse model of pancreatic neuroendocrine tumors.{43204}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • GDC-0326 is an inhibitor of phosphatidylinositol 3-kinase α (PI3Kα; Ki = 0.2 nM) that is 133-, 20-, and 51-fold selective for PI3Kα over PI3Kβ, PI3Kδ, and PI3Kγ, respectively.{43203} It inhibits proliferation of MCF7-neo/HER2 and PC3 cells (EC50s = 0.1 and 2.2 μM, respectively). In vivo, GDC-0326 (6.25 mg/kg) induces tumor regression in a KPL-4 mouse xenograft model. It also reduces tumor growth, tumor vasculature, and the number of liver and lymph node metastases in the RIP1-Tag2 transgenic mouse model of pancreatic neuroendocrine tumors.{43204}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • GDC-0349 is a potent inhibitor of the mammalian target of rapamycin (mTOR; Ki = 3.8 nM).{41444} It is selective for mTOR over a panel of 266 kinases at a concentration of 1 μM. GDC-0349 inhibits proliferation of PC3 prostate cancer cells in vitro (EC50 = 270 nM) and induces caspase-dependent apoptosis in head and neck squamous cell carcinoma (HNSCC) cells via inhibition of mTOR complex 1 (mTORC1) and mTORC2 and induction of autophagy.{41444,41445} Oral administration of GDC-0349 (10-80 mg/kg) inhibits tumor growth in MCF7-neo/Her-2 breast and PC3 prostate cancer mouse xenograft models in a dose-dependent manner. It also reduces tumor growth in an A549 lung cancer mouse xenograft model when administered in combination with the PI3K inhibitor GDC-0941 (Item No. 11600) or the MEK inhibitor cobimetinib (GDC-0973; Item No. 19563).  

     

    Brand:
    Cayman
    SKU:24058 - 1 mg

    Available on backorder

  • GDC-0349 is a potent inhibitor of the mammalian target of rapamycin (mTOR; Ki = 3.8 nM).{41444} It is selective for mTOR over a panel of 266 kinases at a concentration of 1 μM. GDC-0349 inhibits proliferation of PC3 prostate cancer cells in vitro (EC50 = 270 nM) and induces caspase-dependent apoptosis in head and neck squamous cell carcinoma (HNSCC) cells via inhibition of mTOR complex 1 (mTORC1) and mTORC2 and induction of autophagy.{41444,41445} Oral administration of GDC-0349 (10-80 mg/kg) inhibits tumor growth in MCF7-neo/Her-2 breast and PC3 prostate cancer mouse xenograft models in a dose-dependent manner. It also reduces tumor growth in an A549 lung cancer mouse xenograft model when administered in combination with the PI3K inhibitor GDC-0941 (Item No. 11600) or the MEK inhibitor cobimetinib (GDC-0973; Item No. 19563).  

     

    Brand:
    Cayman
    SKU:24058 - 10 mg

    Available on backorder

  • GDC-0349 is a potent inhibitor of the mammalian target of rapamycin (mTOR; Ki = 3.8 nM).{41444} It is selective for mTOR over a panel of 266 kinases at a concentration of 1 μM. GDC-0349 inhibits proliferation of PC3 prostate cancer cells in vitro (EC50 = 270 nM) and induces caspase-dependent apoptosis in head and neck squamous cell carcinoma (HNSCC) cells via inhibition of mTOR complex 1 (mTORC1) and mTORC2 and induction of autophagy.{41444,41445} Oral administration of GDC-0349 (10-80 mg/kg) inhibits tumor growth in MCF7-neo/Her-2 breast and PC3 prostate cancer mouse xenograft models in a dose-dependent manner. It also reduces tumor growth in an A549 lung cancer mouse xenograft model when administered in combination with the PI3K inhibitor GDC-0941 (Item No. 11600) or the MEK inhibitor cobimetinib (GDC-0973; Item No. 19563).  

     

    Brand:
    Cayman
    SKU:24058 - 5 mg

    Available on backorder

  • GDC-0349 is a potent inhibitor of the mammalian target of rapamycin (mTOR; Ki = 3.8 nM).{41444} It is selective for mTOR over a panel of 266 kinases at a concentration of 1 μM. GDC-0349 inhibits proliferation of PC3 prostate cancer cells in vitro (EC50 = 270 nM) and induces caspase-dependent apoptosis in head and neck squamous cell carcinoma (HNSCC) cells via inhibition of mTOR complex 1 (mTORC1) and mTORC2 and induction of autophagy.{41444,41445} Oral administration of GDC-0349 (10-80 mg/kg) inhibits tumor growth in MCF7-neo/Her-2 breast and PC3 prostate cancer mouse xenograft models in a dose-dependent manner. It also reduces tumor growth in an A549 lung cancer mouse xenograft model when administered in combination with the PI3K inhibitor GDC-0941 (Item No. 11600) or the MEK inhibitor cobimetinib (GDC-0973; Item No. 19563).  

     

    Brand:
    Cayman
    SKU:24058 - 500 µg

    Available on backorder

  • GDC-0623 is a potent, ATP-uncompetitive inhibitor of MEK1 (Ki = 0.13 nM in the presence of ATP).{33319} It inhibits the proliferation of A375 BRAF(V600E) and HCT116 KRAS(G13D)-mutant cancer cell lines with EC50 values of 7 and 42 nM, respectively.{33319} GDC-0623 inhibits ERK and BIM phosphorylation resulting in upregulation and stabilization of pro-apoptotic BIM protein in KRAS mutant and wild-type HCT116 cells and in KRAS mutant GW620 cells.{33320}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • GDC-0623 is a potent, ATP-uncompetitive inhibitor of MEK1 (Ki = 0.13 nM in the presence of ATP).{33319} It inhibits the proliferation of A375 BRAF(V600E) and HCT116 KRAS(G13D)-mutant cancer cell lines with EC50 values of 7 and 42 nM, respectively.{33319} GDC-0623 inhibits ERK and BIM phosphorylation resulting in upregulation and stabilization of pro-apoptotic BIM protein in KRAS mutant and wild-type HCT116 cells and in KRAS mutant GW620 cells.{33320}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • GDC-0623 is a potent, ATP-uncompetitive inhibitor of MEK1 (Ki = 0.13 nM in the presence of ATP).{33319} It inhibits the proliferation of A375 BRAF(V600E) and HCT116 KRAS(G13D)-mutant cancer cell lines with EC50 values of 7 and 42 nM, respectively.{33319} GDC-0623 inhibits ERK and BIM phosphorylation resulting in upregulation and stabilization of pro-apoptotic BIM protein in KRAS mutant and wild-type HCT116 cells and in KRAS mutant GW620 cells.{33320}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • GDC-0623 is a potent, ATP-uncompetitive inhibitor of MEK1 (Ki = 0.13 nM in the presence of ATP).{33319} It inhibits the proliferation of A375 BRAF(V600E) and HCT116 KRAS(G13D)-mutant cancer cell lines with EC50 values of 7 and 42 nM, respectively.{33319} GDC-0623 inhibits ERK and BIM phosphorylation resulting in upregulation and stabilization of pro-apoptotic BIM protein in KRAS mutant and wild-type HCT116 cells and in KRAS mutant GW620 cells.{33320}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • GDC-0853 is an orally bioavailable, selective, and reversible Bruton’s tyrosine kinase (BTK) inhibitor with IC50s ranging from 2-9 nM for basophil activation, B cell receptor activation, and constitutive p-BTK activity in whole blood lysates.{34260,34261} In rats, treatment for longer than 7 days leads to pancreatic toxicity but it does not occur in mice or dogs, even at higher doses.{34259} Formulations containing GDC-0853 were well-tolerated in Phase I clinical trials and are in additional clinical trials for rheumatoid arthritis, lupus erythematosus, lymphoma, and leukemia.  

     

    Brand:
    Cayman
    SKU:21346 -

    Out of stock

  • GDC-0853 is an orally bioavailable, selective, and reversible Bruton’s tyrosine kinase (BTK) inhibitor with IC50s ranging from 2-9 nM for basophil activation, B cell receptor activation, and constitutive p-BTK activity in whole blood lysates.{34260,34261} In rats, treatment for longer than 7 days leads to pancreatic toxicity but it does not occur in mice or dogs, even at higher doses.{34259} Formulations containing GDC-0853 were well-tolerated in Phase I clinical trials and are in additional clinical trials for rheumatoid arthritis, lupus erythematosus, lymphoma, and leukemia.  

     

    Brand:
    Cayman
    SKU:21346 -

    Out of stock

  • GDC-0853 is an orally bioavailable, selective, and reversible Bruton’s tyrosine kinase (BTK) inhibitor with IC50s ranging from 2-9 nM for basophil activation, B cell receptor activation, and constitutive p-BTK activity in whole blood lysates.{34260,34261} In rats, treatment for longer than 7 days leads to pancreatic toxicity but it does not occur in mice or dogs, even at higher doses.{34259} Formulations containing GDC-0853 were well-tolerated in Phase I clinical trials and are in additional clinical trials for rheumatoid arthritis, lupus erythematosus, lymphoma, and leukemia.  

     

    Brand:
    Cayman
    SKU:21346 -

    Out of stock

  • GDC-0853 is an orally bioavailable, selective, and reversible Bruton’s tyrosine kinase (BTK) inhibitor with IC50s ranging from 2-9 nM for basophil activation, B cell receptor activation, and constitutive p-BTK activity in whole blood lysates.{34260,34261} In rats, treatment for longer than 7 days leads to pancreatic toxicity but it does not occur in mice or dogs, even at higher doses.{34259} Formulations containing GDC-0853 were well-tolerated in Phase I clinical trials and are in additional clinical trials for rheumatoid arthritis, lupus erythematosus, lymphoma, and leukemia.  

     

    Brand:
    Cayman
    SKU:21346 -

    Out of stock

  • The phosphatidylinositol 3-kinase (PI3K) signaling pathway has central roles in cell growth, development, and survival.{13740,17822} GDC-0941 is a potent pan inhibitor of class I catalytic subunits of PI3K, inhibiting p110α, β, δ, and γ with IC50 values of 3, 33, 3, and 75 nM, respectively.{24602,24604} It is much less effective against class II-IV isoforms of PI3K and against mTOR.{24602,24603} GDC-0941 inhibits the growth of certain types of cancer cells and blocks signaling through PI3K to Akt, both in cells and in vivo.{24602,24605}  

     

    Brand:
    Cayman
    SKU:11600 - 10 mg

    Available on backorder

  • The phosphatidylinositol 3-kinase (PI3K) signaling pathway has central roles in cell growth, development, and survival.{13740,17822} GDC-0941 is a potent pan inhibitor of class I catalytic subunits of PI3K, inhibiting p110α, β, δ, and γ with IC50 values of 3, 33, 3, and 75 nM, respectively.{24602,24604} It is much less effective against class II-IV isoforms of PI3K and against mTOR.{24602,24603} GDC-0941 inhibits the growth of certain types of cancer cells and blocks signaling through PI3K to Akt, both in cells and in vivo.{24602,24605}  

     

    Brand:
    Cayman
    SKU:11600 - 100 mg

    Available on backorder

  • The phosphatidylinositol 3-kinase (PI3K) signaling pathway has central roles in cell growth, development, and survival.{13740,17822} GDC-0941 is a potent pan inhibitor of class I catalytic subunits of PI3K, inhibiting p110α, β, δ, and γ with IC50 values of 3, 33, 3, and 75 nM, respectively.{24602,24604} It is much less effective against class II-IV isoforms of PI3K and against mTOR.{24602,24603} GDC-0941 inhibits the growth of certain types of cancer cells and blocks signaling through PI3K to Akt, both in cells and in vivo.{24602,24605}  

     

    Brand:
    Cayman
    SKU:11600 - 50 mg

    Available on backorder

  • GDC-0980 is a potent inhibitor of class I phosphatidylinositol 3-kinase (PI3K) isoforms, with IC50 values of 5, 27, 7, and 14 nM for PI3Kα, β, δ, and γ, respectively, in cell-free assays.{29877,29878} It also inhibits mTOR (Ki = 17 nM) but is inactive against a large panel of additional kinases.{29877,29878} GDC-0980 induces cell cycle arrest or apoptosis in a range of cancer cell lines.{29878} It is effective in vivo, suppressing the growth of a number of tumor xenografts in mice and enhancing the antitumor activity of docetaxel (Item No. 11637) in mice.{29878}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • GDC-0980 is a potent inhibitor of class I phosphatidylinositol 3-kinase (PI3K) isoforms, with IC50 values of 5, 27, 7, and 14 nM for PI3Kα, β, δ, and γ, respectively, in cell-free assays.{29877,29878} It also inhibits mTOR (Ki = 17 nM) but is inactive against a large panel of additional kinases.{29877,29878} GDC-0980 induces cell cycle arrest or apoptosis in a range of cancer cell lines.{29878} It is effective in vivo, suppressing the growth of a number of tumor xenografts in mice and enhancing the antitumor activity of docetaxel (Item No. 11637) in mice.{29878}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder

  • GDC-0980 is a potent inhibitor of class I phosphatidylinositol 3-kinase (PI3K) isoforms, with IC50 values of 5, 27, 7, and 14 nM for PI3Kα, β, δ, and γ, respectively, in cell-free assays.{29877,29878} It also inhibits mTOR (Ki = 17 nM) but is inactive against a large panel of additional kinases.{29877,29878} GDC-0980 induces cell cycle arrest or apoptosis in a range of cancer cell lines.{29878} It is effective in vivo, suppressing the growth of a number of tumor xenografts in mice and enhancing the antitumor activity of docetaxel (Item No. 11637) in mice.{29878}  

     

    Brand:
    Cayman
    SKU:-

    Available on backorder